BR112021004670A2 - reprogramação celular para reverter o envelhecimento e promover a regeneração de órgãos e tecidos - Google Patents

Info

Publication number

BR112021004670A2

BR112021004670A2 BR112021004670-4A BR112021004670A BR112021004670A2 BR 112021004670 A2 BR112021004670 A2 BR 112021004670A2 BR 112021004670 A BR112021004670 A BR 112021004670A BR 112021004670 A2 BR112021004670 A2 BR 112021004670A2

Authority

BR

Brazil

Prior art keywords

expression

klf4

nucleic acid

oct4

sox2

Prior art date

2018-09-28

Links

• Espacenet
• Global Dossier
• Discuss

• 230000032683 aging Effects 0.000 title claims abstract description 49
• 230000008672 reprogramming Effects 0.000 title claims abstract description 27
• 210000000056 organ Anatomy 0.000 title claims description 51
• 230000002441 reversible effect Effects 0.000 title claims description 20
• 230000017423 tissue regeneration Effects 0.000 title abstract description 24
• 230000033667 organ regeneration Effects 0.000 title abstract description 11
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 372
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 339
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 339
• 230000014509 gene expression Effects 0.000 claims abstract description 180
• 230000001939 inductive effect Effects 0.000 claims abstract description 180
• 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims abstract description 176
• 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 claims abstract description 171
• 102100020677 Krueppel-like factor 4 Human genes 0.000 claims abstract description 171
• 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims abstract description 167
• 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims abstract description 157
• 102100024270 Transcription factor SOX-2 Human genes 0.000 claims abstract description 154
• 238000000034 method Methods 0.000 claims abstract description 117
• 239000013604 expression vector Substances 0.000 claims abstract description 84
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 79
• 239000000203 mixture Substances 0.000 claims abstract description 65
• 201000010099 disease Diseases 0.000 claims abstract description 64
• 239000013598 vector Substances 0.000 claims abstract description 60
• 208000030533 eye disease Diseases 0.000 claims abstract description 30
• 241001430294 unidentified retrovirus Species 0.000 claims abstract description 19
• 239000013603 viral vector Substances 0.000 claims abstract description 19
• 241000710929 Alphavirus Species 0.000 claims abstract description 18
• 241000713666 Lentivirus Species 0.000 claims abstract description 18
• 241000700618 Vaccinia virus Species 0.000 claims abstract description 18
• 241000701161 unidentified adenovirus Species 0.000 claims abstract description 18
• 239000013607 AAV vector Substances 0.000 claims abstract description 11
• 241000702421 Dependoparvovirus Species 0.000 claims abstract description 11
• 210000004027 cell Anatomy 0.000 claims description 170
• 210000001519 tissue Anatomy 0.000 claims description 112
• 239000003795 chemical substances by application Substances 0.000 claims description 102
• 108091023040 Transcription factor Proteins 0.000 claims description 87
• 102000040945 Transcription factor Human genes 0.000 claims description 81
• 229930101283 tetracycline Natural products 0.000 claims description 66
• 239000004098 Tetracycline Substances 0.000 claims description 65
• 229960002180 tetracycline Drugs 0.000 claims description 65
• 235000019364 tetracycline Nutrition 0.000 claims description 65
• 150000003522 tetracyclines Chemical class 0.000 claims description 65
• SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims description 51
• 229960003722 doxycycline Drugs 0.000 claims description 51
• 206010028980 Neoplasm Diseases 0.000 claims description 37
• 230000006378 damage Effects 0.000 claims description 33
• 208000014674 injury Diseases 0.000 claims description 33
• 208000027418 Wounds and injury Diseases 0.000 claims description 30
• 108020004414 DNA Proteins 0.000 claims description 27
• 230000001973 epigenetic effect Effects 0.000 claims description 27
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 24
• 230000003716 rejuvenation Effects 0.000 claims description 15
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
• 201000011510 cancer Diseases 0.000 claims description 13
• 238000001727 in vivo Methods 0.000 claims description 13
• 241000282414 Homo sapiens Species 0.000 claims description 12
• 101000712899 Homo sapiens RNA-binding protein with multiple splicing Proteins 0.000 claims description 12
• 102100033135 RNA-binding protein with multiple splicing Human genes 0.000 claims description 12
• 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 11
• 108020004999 messenger RNA Proteins 0.000 claims description 11
• 210000003205 muscle Anatomy 0.000 claims description 11
• 210000004556 brain Anatomy 0.000 claims description 10
• 101000643895 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 6 Proteins 0.000 claims description 9
• 102100021015 Ubiquitin carboxyl-terminal hydrolase 6 Human genes 0.000 claims description 9
• 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 8
• 210000000988 bone and bone Anatomy 0.000 claims description 8
• 210000004185 liver Anatomy 0.000 claims description 8
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
• 210000003491 skin Anatomy 0.000 claims description 7
• 210000000481 breast Anatomy 0.000 claims description 6
• 210000004072 lung Anatomy 0.000 claims description 6
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 6
• 239000013612 plasmid Substances 0.000 claims description 6
• 210000000130 stem cell Anatomy 0.000 claims description 6
• 108700021430 Kruppel-Like Factor 4 Proteins 0.000 claims description 5
• 210000002216 heart Anatomy 0.000 claims description 5
• 210000003734 kidney Anatomy 0.000 claims description 5
• 230000004770 neurodegeneration Effects 0.000 claims description 5
• 210000000496 pancreas Anatomy 0.000 claims description 5
• 229920001184 polypeptide Polymers 0.000 claims description 5
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 4
• 210000004204 blood vessel Anatomy 0.000 claims description 4
• 238000003776 cleavage reaction Methods 0.000 claims description 4
• 210000004209 hair Anatomy 0.000 claims description 4
• 239000002105 nanoparticle Substances 0.000 claims description 4
• 230000007017 scission Effects 0.000 claims description 4
• 208000023178 Musculoskeletal disease Diseases 0.000 claims description 3
• 108091027981 Response element Proteins 0.000 claims description 3
• 210000003555 cloaca Anatomy 0.000 claims description 3
• 230000004069 differentiation Effects 0.000 claims description 3
• 210000003238 esophagus Anatomy 0.000 claims description 3
• 230000004720 fertilization Effects 0.000 claims description 3
• 210000000936 intestine Anatomy 0.000 claims description 3
• 101150111214 lin-28 gene Proteins 0.000 claims description 3
• 239000003550 marker Substances 0.000 claims description 3
• 210000004165 myocardium Anatomy 0.000 claims description 3
• 210000000944 nerve tissue Anatomy 0.000 claims description 3
• 210000001672 ovary Anatomy 0.000 claims description 3
• 210000003899 penis Anatomy 0.000 claims description 3
• 210000002307 prostate Anatomy 0.000 claims description 3
• 210000002784 stomach Anatomy 0.000 claims description 3
• 210000001550 testis Anatomy 0.000 claims description 3
• 101150099612 Esrrb gene Proteins 0.000 claims description 2
• 101150008375 Pou4f1 gene Proteins 0.000 claims description 2
• 101800001494 Protease 2A Proteins 0.000 claims description 2
• 101800001066 Protein 2A Proteins 0.000 claims description 2
• 239000002771 cell marker Substances 0.000 claims description 2
• 208000017445 musculoskeletal system disease Diseases 0.000 claims description 2
• 150000003384 small molecules Chemical class 0.000 claims 1
• 210000000515 tooth Anatomy 0.000 claims 1
• 241000700605 Viruses Species 0.000 abstract description 73
• 230000003213 activating effect Effects 0.000 abstract description 36
• -1 expression vectors Chemical class 0.000 abstract description 32
• 239000013043 chemical agent Substances 0.000 abstract description 25
• 230000006698 induction Effects 0.000 abstract description 25
• 230000001105 regulatory effect Effects 0.000 abstract description 23
• 102000035118 modified proteins Human genes 0.000 abstract description 22
• 108091005573 modified proteins Proteins 0.000 abstract description 22
• 241001529453 unidentified herpesvirus Species 0.000 abstract description 16
• 230000008668 cellular reprogramming Effects 0.000 abstract description 8
• 230000033228 biological regulation Effects 0.000 abstract description 7
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 abstract description 4
• 230000001177 retroviral effect Effects 0.000 abstract description 4
• 241000175212 Herpesvirales Species 0.000 abstract description 2
• 108090000623 proteins and genes Proteins 0.000 description 72
• 230000000694 effects Effects 0.000 description 29
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 28
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 28
• 108091028043 Nucleic acid sequence Proteins 0.000 description 28
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 28
• 102000004169 proteins and genes Human genes 0.000 description 28
• 210000003994 retinal ganglion cell Anatomy 0.000 description 28
• 230000000670 limiting effect Effects 0.000 description 27
• 238000011282 treatment Methods 0.000 description 25
• 208000002193 Pain Diseases 0.000 description 24
• 125000003275 alpha amino acid group Chemical group 0.000 description 24
• 235000018102 proteins Nutrition 0.000 description 23
• 230000004083 survival effect Effects 0.000 description 23
• 241000699670 Mus sp. Species 0.000 description 21
• 210000003050 axon Anatomy 0.000 description 21
• 230000006870 function Effects 0.000 description 20
• 230000001413 cellular effect Effects 0.000 description 19
• 230000036407 pain Effects 0.000 description 19
• 210000001328 optic nerve Anatomy 0.000 description 18
• 230000008929 regeneration Effects 0.000 description 18
• 238000011069 regeneration method Methods 0.000 description 18
• 208000011580 syndromic disease Diseases 0.000 description 18
• 239000002773 nucleotide Substances 0.000 description 16
• 125000003729 nucleotide group Chemical group 0.000 description 16
• 230000001737 promoting effect Effects 0.000 description 16
• 230000007067 DNA methylation Effects 0.000 description 15
• 241000699666 Mus <mouse, genus> Species 0.000 description 15
• 208000035032 Multiple sulfatase deficiency Diseases 0.000 description 14
• 230000001965 increasing effect Effects 0.000 description 14
• 201000006033 mucosulfatidosis Diseases 0.000 description 14
• 206010061218 Inflammation Diseases 0.000 description 13
• 208000035475 disorder Diseases 0.000 description 13
• 210000001508 eye Anatomy 0.000 description 13
• 230000004054 inflammatory process Effects 0.000 description 13
• 108700019146 Transgenes Proteins 0.000 description 12
• 239000005090 green fluorescent protein Substances 0.000 description 12
• 230000002103 transcriptional effect Effects 0.000 description 12
• 238000013518 transcription Methods 0.000 description 11
• 230000035897 transcription Effects 0.000 description 11
• 208000025962 Crush injury Diseases 0.000 description 10
• 241001465754 Metazoa Species 0.000 description 10
• 230000004048 modification Effects 0.000 description 10
• 238000012986 modification Methods 0.000 description 10
• 210000005036 nerve Anatomy 0.000 description 10
• 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 9
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 9
• 206010025323 Lymphomas Diseases 0.000 description 9
• 239000004472 Lysine Substances 0.000 description 9
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
• 235000018977 lysine Nutrition 0.000 description 9
• 210000001525 retina Anatomy 0.000 description 9
• 230000009758 senescence Effects 0.000 description 9
• 108020005544 Antisense RNA Proteins 0.000 description 8
• 208000010412 Glaucoma Diseases 0.000 description 8
• 108010033040 Histones Proteins 0.000 description 8
• 230000027455 binding Effects 0.000 description 8
• 239000003184 complementary RNA Substances 0.000 description 8
• 230000007423 decrease Effects 0.000 description 8
• 230000003612 virological effect Effects 0.000 description 8
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 7
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 7
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 7
• 208000026350 Inborn Genetic disease Diseases 0.000 description 7
• 241000124008 Mammalia Species 0.000 description 7
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 7
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 7
• 208000028389 Nerve injury Diseases 0.000 description 7
• 208000004286 Osteochondrodysplasias Diseases 0.000 description 7
• 206010043276 Teratoma Diseases 0.000 description 7
• 210000003169 central nervous system Anatomy 0.000 description 7
• 230000004064 dysfunction Effects 0.000 description 7
• 230000012010 growth Effects 0.000 description 7
• 230000001976 improved effect Effects 0.000 description 7
• 208000027866 inflammatory disease Diseases 0.000 description 7
• 201000008482 osteoarthritis Diseases 0.000 description 7
• 102000040430 polynucleotide Human genes 0.000 description 7
• 108091033319 polynucleotide Proteins 0.000 description 7
• 239000002157 polynucleotide Substances 0.000 description 7
• 230000008569 process Effects 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 238000010186 staining Methods 0.000 description 7
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 6
• 208000024827 Alzheimer disease Diseases 0.000 description 6
• 241000272517 Anseriformes Species 0.000 description 6
• 208000023275 Autoimmune disease Diseases 0.000 description 6
• 241000271566 Aves Species 0.000 description 6
• 208000007465 Giant cell arteritis Diseases 0.000 description 6
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 6
• 208000012902 Nervous system disease Diseases 0.000 description 6
• 208000025966 Neurological disease Diseases 0.000 description 6
• 206010035664 Pneumonia Diseases 0.000 description 6
• 230000002159 abnormal effect Effects 0.000 description 6
• 230000000692 anti-sense effect Effects 0.000 description 6
• 206010003246 arthritis Diseases 0.000 description 6
• 208000006673 asthma Diseases 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 208000016361 genetic disease Diseases 0.000 description 6
• 208000006454 hepatitis Diseases 0.000 description 6
• 230000003902 lesion Effects 0.000 description 6
• 208000002780 macular degeneration Diseases 0.000 description 6
• 239000008194 pharmaceutical composition Substances 0.000 description 6
• 208000020016 psychiatric disease Diseases 0.000 description 6
• 208000002574 reactive arthritis Diseases 0.000 description 6
• 230000002207 retinal effect Effects 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 5
• 206010003267 Arthritis reactive Diseases 0.000 description 5
• 108020004635 Complementary DNA Proteins 0.000 description 5
• 206010012289 Dementia Diseases 0.000 description 5
• 201000005569 Gout Diseases 0.000 description 5
• 108010034791 Heterochromatin Proteins 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 101100137155 Homo sapiens POU5F1 gene Proteins 0.000 description 5
• 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 5
• 208000029523 Interstitial Lung disease Diseases 0.000 description 5
• 208000016604 Lyme disease Diseases 0.000 description 5
• 206010027476 Metastases Diseases 0.000 description 5
• 108091034117 Oligonucleotide Proteins 0.000 description 5
• KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 5
• 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 5
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 5
• 208000017442 Retinal disease Diseases 0.000 description 5
• 201000004810 Vascular dementia Diseases 0.000 description 5
• 230000021736 acetylation Effects 0.000 description 5
• 238000006640 acetylation reaction Methods 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 238000010804 cDNA synthesis Methods 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 201000001981 dermatomyositis Diseases 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 5
• 210000004458 heterochromatin Anatomy 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 208000015181 infectious disease Diseases 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 230000008764 nerve damage Effects 0.000 description 5
• 208000004296 neuralgia Diseases 0.000 description 5
• 208000021722 neuropathic pain Diseases 0.000 description 5
• 210000000952 spleen Anatomy 0.000 description 5
• 206010043207 temporal arteritis Diseases 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 206010060999 Benign neoplasm Diseases 0.000 description 4
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 4
• 208000020925 Bipolar disease Diseases 0.000 description 4
• 108091033409 CRISPR Proteins 0.000 description 4
• 208000012514 Cumulative Trauma disease Diseases 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 108010022894 Euchromatin Proteins 0.000 description 4
• 108020005004 Guide RNA Proteins 0.000 description 4
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 4
• 102100033636 Histone H3.2 Human genes 0.000 description 4
• 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 4
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 4
• 101100477623 Mus musculus Skint3 gene Proteins 0.000 description 4
• 101100477625 Mus musculus Skint5 gene Proteins 0.000 description 4
• 208000009905 Neurofibromatoses Diseases 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• 206010060862 Prostate cancer Diseases 0.000 description 4
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 4
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 4
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 4
• 108020004511 Recombinant DNA Proteins 0.000 description 4
• 208000005587 Refsum Disease Diseases 0.000 description 4
• 201000000582 Retinoblastoma Diseases 0.000 description 4
• 208000021386 Sjogren Syndrome Diseases 0.000 description 4
• 210000001744 T-lymphocyte Anatomy 0.000 description 4
• 206010046851 Uveitis Diseases 0.000 description 4
• 208000009956 adenocarcinoma Diseases 0.000 description 4
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 4
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• 206010006451 bronchitis Diseases 0.000 description 4
• 210000003161 choroid Anatomy 0.000 description 4
• 210000004087 cornea Anatomy 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 230000003247 decreasing effect Effects 0.000 description 4
• 206010012601 diabetes mellitus Diseases 0.000 description 4
• 206010013663 drug dependence Diseases 0.000 description 4
• 210000000632 euchromatin Anatomy 0.000 description 4
• 239000004744 fabric Substances 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 208000014951 hematologic disease Diseases 0.000 description 4
• 231100000283 hepatitis Toxicity 0.000 description 4
• 102000047444 human SOX2 Human genes 0.000 description 4
• 230000002757 inflammatory effect Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 208000032839 leukemia Diseases 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 208000019423 liver disease Diseases 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 208000030159 metabolic disease Diseases 0.000 description 4
• 229910052751 metal Inorganic materials 0.000 description 4
• 239000002184 metal Substances 0.000 description 4
• 230000009401 metastasis Effects 0.000 description 4
• 208000005264 motor neuron disease Diseases 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• 201000005962 mycosis fungoides Diseases 0.000 description 4
• 206010028537 myelofibrosis Diseases 0.000 description 4
• 201000004931 neurofibromatosis Diseases 0.000 description 4
• 230000000750 progressive effect Effects 0.000 description 4
• 230000002062 proliferating effect Effects 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 201000003068 rheumatic fever Diseases 0.000 description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 description 4
• 210000001082 somatic cell Anatomy 0.000 description 4
• 208000002320 spinal muscular atrophy Diseases 0.000 description 4
• 206010041823 squamous cell carcinoma Diseases 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 230000001629 suppression Effects 0.000 description 4
• 201000004595 synovitis Diseases 0.000 description 4
• 230000008467 tissue growth Effects 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 238000001262 western blot Methods 0.000 description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
• BLQMCTXZEMGOJM-UHFFFAOYSA-N 5-carboxycytosine Chemical compound NC=1NC(=O)N=CC=1C(O)=O BLQMCTXZEMGOJM-UHFFFAOYSA-N 0.000 description 3
• 208000030507 AIDS Diseases 0.000 description 3
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 3
• 201000004384 Alopecia Diseases 0.000 description 3
• 208000000044 Amnesia Diseases 0.000 description 3
• 201000003076 Angiosarcoma Diseases 0.000 description 3
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 3
• 206010003591 Ataxia Diseases 0.000 description 3
• 201000001320 Atherosclerosis Diseases 0.000 description 3
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 3
• 206010003805 Autism Diseases 0.000 description 3
• 208000020706 Autistic disease Diseases 0.000 description 3
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
• 208000009766 Blau syndrome Diseases 0.000 description 3
• 201000004569 Blindness Diseases 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 241000282472 Canis lupus familiaris Species 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 208000002177 Cataract Diseases 0.000 description 3
• 206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 3
• 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 3
• 206010008723 Chondrodystrophy Diseases 0.000 description 3
• 208000017667 Chronic Disease Diseases 0.000 description 3
• 208000000094 Chronic Pain Diseases 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 208000035473 Communicable disease Diseases 0.000 description 3
• 206010010741 Conjunctivitis Diseases 0.000 description 3
• 208000011231 Crohn disease Diseases 0.000 description 3
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
• 206010012689 Diabetic retinopathy Diseases 0.000 description 3
• 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
• 206010013774 Dry eye Diseases 0.000 description 3
• 206010058314 Dysplasia Diseases 0.000 description 3
• 241000283086 Equidae Species 0.000 description 3
• 208000006168 Ewing Sarcoma Diseases 0.000 description 3
• 241000282326 Felis catus Species 0.000 description 3
• 208000028387 Felty syndrome Diseases 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• 201000011240 Frontotemporal dementia Diseases 0.000 description 3
• 108091004242 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 description 3
• 102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 description 3
• 241000287828 Gallus gallus Species 0.000 description 3
• 208000024869 Goodpasture syndrome Diseases 0.000 description 3
• 108700017799 HPRT-Related Gout Proteins 0.000 description 3
• 208000027408 HRPT-related hyperuricemia Diseases 0.000 description 3
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 3
• 206010019233 Headaches Diseases 0.000 description 3
• 208000001258 Hemangiosarcoma Diseases 0.000 description 3
• 208000005176 Hepatitis C Diseases 0.000 description 3
• 208000007514 Herpes zoster Diseases 0.000 description 3
• 208000017604 Hodgkin disease Diseases 0.000 description 3
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
• 101100510266 Homo sapiens KLF4 gene Proteins 0.000 description 3
• 206010065390 Inflammatory pain Diseases 0.000 description 3
• 206010048804 Kearns-Sayre syndrome Diseases 0.000 description 3
• 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 3
• 208000018142 Leiomyosarcoma Diseases 0.000 description 3
• 201000001934 Leri-Weill dyschondrosteosis Diseases 0.000 description 3
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 3
• 208000019693 Lung disease Diseases 0.000 description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
• 241000282567 Macaca fascicularis Species 0.000 description 3
• 241000282560 Macaca mulatta Species 0.000 description 3
• 208000026139 Memory disease Diseases 0.000 description 3
• 208000001089 Multiple system atrophy Diseases 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 208000000112 Myalgia Diseases 0.000 description 3
• 206010028424 Myasthenic syndrome Diseases 0.000 description 3
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 3
• 208000014767 Myeloproliferative disease Diseases 0.000 description 3
• 208000010316 Myotonia congenita Diseases 0.000 description 3
• 208000001294 Nociceptive Pain Diseases 0.000 description 3
• 208000005225 Opsoclonus-Myoclonus Syndrome Diseases 0.000 description 3
• 206010031127 Orthostatic hypotension Diseases 0.000 description 3
• 201000009859 Osteochondrosis Diseases 0.000 description 3
• 206010033701 Papillary thyroid cancer Diseases 0.000 description 3
• 208000035318 Partial hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 3
• 241001494479 Pecora Species 0.000 description 3
• 241000286209 Phasianidae Species 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 101710182846 Polyhedrin Proteins 0.000 description 3
• 208000007048 Polymyalgia Rheumatica Diseases 0.000 description 3
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 208000028017 Psychotic disease Diseases 0.000 description 3
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 3
• 108090000799 Rhodopsin kinases Proteins 0.000 description 3
• 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 3
• 108020005543 Satellite RNA Proteins 0.000 description 3
• 201000003696 Sotos syndrome Diseases 0.000 description 3
• 208000004350 Strabismus Diseases 0.000 description 3
• 208000006011 Stroke Diseases 0.000 description 3
• 241000282887 Suidae Species 0.000 description 3
• 206010042953 Systemic sclerosis Diseases 0.000 description 3
• 101150001810 TEAD1 gene Proteins 0.000 description 3
• 101150074253 TEF1 gene Proteins 0.000 description 3
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 3
• 108010048992 Transcription Factor 4 Proteins 0.000 description 3
• 102100023489 Transcription factor 4 Human genes 0.000 description 3
• 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 3
• 108091093126 WHP Posttrascriptional Response Element Proteins 0.000 description 3
• 201000011032 Werner Syndrome Diseases 0.000 description 3
• 208000008383 Wilms tumor Diseases 0.000 description 3
• 208000018839 Wilson disease Diseases 0.000 description 3
• 201000004525 Zellweger Syndrome Diseases 0.000 description 3
• 208000036813 Zellweger spectrum disease Diseases 0.000 description 3
• 208000008919 achondroplasia Diseases 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 208000017733 acquired polycythemia vera Diseases 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 201000009310 astigmatism Diseases 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 230000031018 biological processes and functions Effects 0.000 description 3
• 208000010217 blepharitis Diseases 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 208000002458 carcinoid tumor Diseases 0.000 description 3
• 235000013330 chicken meat Nutrition 0.000 description 3
• 201000004709 chorioretinitis Diseases 0.000 description 3
• 208000019425 cirrhosis of liver Diseases 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 208000031513 cyst Diseases 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 230000013020 embryo development Effects 0.000 description 3
• 206010014599 encephalitis Diseases 0.000 description 3
• 208000010706 fatty liver disease Diseases 0.000 description 3
• 108040001860 guanyl-nucleotide exchange factor activity proteins Proteins 0.000 description 3
• 201000009277 hairy cell leukemia Diseases 0.000 description 3
• 231100000869 headache Toxicity 0.000 description 3
• 208000025750 heavy chain disease Diseases 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 210000004347 intestinal mucosa Anatomy 0.000 description 3
• 230000000366 juvenile effect Effects 0.000 description 3
• 206010023332 keratitis Diseases 0.000 description 3
• 208000014018 liver neoplasm Diseases 0.000 description 3
• 201000005202 lung cancer Diseases 0.000 description 3
• 208000020816 lung neoplasm Diseases 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 230000004060 metabolic process Effects 0.000 description 3
• 150000002739 metals Chemical class 0.000 description 3
• 230000011987 methylation Effects 0.000 description 3
• 238000007069 methylation reaction Methods 0.000 description 3
• 201000006417 multiple sclerosis Diseases 0.000 description 3
• 201000006938 muscular dystrophy Diseases 0.000 description 3
• 206010028417 myasthenia gravis Diseases 0.000 description 3
• 210000002569 neuron Anatomy 0.000 description 3
• 108091027963 non-coding RNA Proteins 0.000 description 3
• 102000042567 non-coding RNA Human genes 0.000 description 3
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
• 206010030875 ophthalmoplegia Diseases 0.000 description 3
• 238000012014 optical coherence tomography Methods 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 239000002245 particle Substances 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 230000001575 pathological effect Effects 0.000 description 3
• 208000033808 peripheral neuropathy Diseases 0.000 description 3
• 230000002085 persistent effect Effects 0.000 description 3
• 208000022821 personality disease Diseases 0.000 description 3
• 208000037244 polycythemia vera Diseases 0.000 description 3
• 208000005987 polymyositis Diseases 0.000 description 3
• 208000003476 primary myelofibrosis Diseases 0.000 description 3
• 208000029340 primitive neuroectodermal tumor Diseases 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 201000000980 schizophrenia Diseases 0.000 description 3
• 239000004055 small Interfering RNA Substances 0.000 description 3
• 208000000587 small cell lung carcinoma Diseases 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 206010062920 spondyloepiphyseal dysplasia Diseases 0.000 description 3
• 201000003504 spondyloepiphyseal dysplasia congenita Diseases 0.000 description 3
• 201000002962 spondyloepiphyseal dysplasia with congenital joint dislocations Diseases 0.000 description 3
• 125000001424 substituent group Chemical group 0.000 description 3
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 230000008733 trauma Effects 0.000 description 3
• 201000008827 tuberculosis Diseases 0.000 description 3
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
• 208000006542 von Hippel-Lindau disease Diseases 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 2
• 208000010543 22q11.2 deletion syndrome Diseases 0.000 description 2
• MJEQLGCFPLHMNV-UHFFFAOYSA-N 4-amino-1-(hydroxymethyl)pyrimidin-2-one Chemical compound NC=1C=CN(CO)C(=O)N=1 MJEQLGCFPLHMNV-UHFFFAOYSA-N 0.000 description 2
• FHSISDGOVSHJRW-UHFFFAOYSA-N 5-formylcytosine Chemical compound NC1=NC(=O)NC=C1C=O FHSISDGOVSHJRW-UHFFFAOYSA-N 0.000 description 2
• LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
• 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 2
• 239000005964 Acibenzolar-S-methyl Substances 0.000 description 2
• 206010000890 Acute myelomonocytic leukaemia Diseases 0.000 description 2
• 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 2
• 241001655883 Adeno-associated virus - 1 Species 0.000 description 2
• 241000202702 Adeno-associated virus - 3 Species 0.000 description 2
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 2
• 241001634120 Adeno-associated virus - 5 Species 0.000 description 2
• 241000972680 Adeno-associated virus - 6 Species 0.000 description 2
• 241001164823 Adeno-associated virus - 7 Species 0.000 description 2
• 241001164825 Adeno-associated virus - 8 Species 0.000 description 2
• 241000649045 Adeno-associated virus 10 Species 0.000 description 2
• 241000649046 Adeno-associated virus 11 Species 0.000 description 2
• 201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
• 201000011374 Alagille syndrome Diseases 0.000 description 2
• 208000031277 Amaurotic familial idiocy Diseases 0.000 description 2
• 201000009487 Amblyopia Diseases 0.000 description 2
• 208000006503 Amebic Liver Abscess Diseases 0.000 description 2
• 208000009575 Angelman syndrome Diseases 0.000 description 2
• 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 2
• 108020004491 Antisense DNA Proteins 0.000 description 2
• 206010002941 Apallic syndrome Diseases 0.000 description 2
• 206010073360 Appendix cancer Diseases 0.000 description 2
• 206010003101 Arnold-Chiari Malformation Diseases 0.000 description 2
• 108050003620 Arrestin-C Proteins 0.000 description 2
• 102100026440 Arrestin-C Human genes 0.000 description 2
• 208000006820 Arthralgia Diseases 0.000 description 2
• 208000033116 Asbestos intoxication Diseases 0.000 description 2
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 2
• 206010003694 Atrophy Diseases 0.000 description 2
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 2
• 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 2
• 208000008035 Back Pain Diseases 0.000 description 2
• 201000005943 Barth syndrome Diseases 0.000 description 2
• 206010004146 Basal cell carcinoma Diseases 0.000 description 2
• 208000006373 Bell palsy Diseases 0.000 description 2
• 208000034577 Benign intracranial hypertension Diseases 0.000 description 2
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 2
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
• 208000010392 Bone Fractures Diseases 0.000 description 2
• 206010005949 Bone cancer Diseases 0.000 description 2
• 208000018084 Bone neoplasm Diseases 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 206010006458 Bronchitis chronic Diseases 0.000 description 2
• 208000011691 Burkitt lymphomas Diseases 0.000 description 2
• 101150112561 CD36 gene Proteins 0.000 description 2
• 201000004085 CLL/SLL Diseases 0.000 description 2
• 238000010354 CRISPR gene editing Methods 0.000 description 2
• 206010007275 Carcinoid tumour Diseases 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 208000001387 Causalgia Diseases 0.000 description 2
• 201000006867 Charcot-Marie-Tooth disease type 4 Diseases 0.000 description 2
• 208000015321 Chiari malformation Diseases 0.000 description 2
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 2
• 102000009016 Cholera Toxin Human genes 0.000 description 2
• 108010049048 Cholera Toxin Proteins 0.000 description 2
• 208000033825 Chorioretinal atrophy Diseases 0.000 description 2
• 208000033810 Choroidal dystrophy Diseases 0.000 description 2
• 101150064250 Chrna4 gene Proteins 0.000 description 2
• 208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 description 2
• 208000010200 Cockayne syndrome Diseases 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 208000001353 Coffin-Lowry syndrome Diseases 0.000 description 2
• 206010009900 Colitis ulcerative Diseases 0.000 description 2
• 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 2
• 208000006992 Color Vision Defects Diseases 0.000 description 2
• 206010010071 Coma Diseases 0.000 description 2
• 206010010984 Corneal abrasion Diseases 0.000 description 2
• 208000028006 Corneal injury Diseases 0.000 description 2
• 206010055665 Corneal neovascularisation Diseases 0.000 description 2
• 208000009283 Craniosynostoses Diseases 0.000 description 2
• 206010049889 Craniosynostosis Diseases 0.000 description 2
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
• 208000014311 Cushing syndrome Diseases 0.000 description 2
• 201000003883 Cystic fibrosis Diseases 0.000 description 2
• 206010011831 Cytomegalovirus infection Diseases 0.000 description 2
• 230000004543 DNA replication Effects 0.000 description 2
• 230000004568 DNA-binding Effects 0.000 description 2
• 101150049660 DRD2 gene Proteins 0.000 description 2
• 206010011878 Deafness Diseases 0.000 description 2
• 208000016192 Demyelinating disease Diseases 0.000 description 2
• 206010012335 Dependence Diseases 0.000 description 2
• 208000004986 Diffuse Cerebral Sclerosis of Schilder Diseases 0.000 description 2
• 201000008009 Early infantile epileptic encephalopathy Diseases 0.000 description 2
• 206010014561 Emphysema Diseases 0.000 description 2
• 208000032027 Essential Thrombocythemia Diseases 0.000 description 2
• 208000004930 Fatty Liver Diseases 0.000 description 2
• 208000001640 Fibromyalgia Diseases 0.000 description 2
• 201000008808 Fibrosarcoma Diseases 0.000 description 2
• 208000024412 Friedreich ataxia Diseases 0.000 description 2
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 2
• 101150003543 GPRC5C gene Proteins 0.000 description 2
• 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 2
• 208000015872 Gaucher disease Diseases 0.000 description 2
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 2
• 206010018364 Glomerulonephritis Diseases 0.000 description 2
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
• 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 2
• 206010018634 Gouty Arthritis Diseases 0.000 description 2
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 2
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 2
• 206010019196 Head injury Diseases 0.000 description 2
• 208000002125 Hemangioendothelioma Diseases 0.000 description 2
• 208000031220 Hemophilia Diseases 0.000 description 2
• 208000009292 Hemophilia A Diseases 0.000 description 2
• 206010019629 Hepatic adenoma Diseases 0.000 description 2
• 206010063741 Hepatic amoebiasis Diseases 0.000 description 2
• 206010019708 Hepatic steatosis Diseases 0.000 description 2
• 208000005331 Hepatitis D Diseases 0.000 description 2
• 206010019842 Hepatomegaly Diseases 0.000 description 2
• 208000006411 Hereditary Sensory and Motor Neuropathy Diseases 0.000 description 2
• 108020004996 Heterogeneous Nuclear RNA Proteins 0.000 description 2
• 102100039869 Histone H2B type F-S Human genes 0.000 description 2
• 102000006947 Histones Human genes 0.000 description 2
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
• 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 2
• 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 2
• 102000003839 Human Proteins Human genes 0.000 description 2
• 108090000144 Human Proteins Proteins 0.000 description 2
• 208000023105 Huntington disease Diseases 0.000 description 2
• 208000025500 Hutchinson-Gilford progeria syndrome Diseases 0.000 description 2
• 206010048643 Hypereosinophilic syndrome Diseases 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
• 206010061213 Iatrogenic injury Diseases 0.000 description 2
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 2
• 208000018127 Idiopathic intracranial hypertension Diseases 0.000 description 2
• 206010021750 Infantile Spasms Diseases 0.000 description 2
• 206010061216 Infarction Diseases 0.000 description 2
• 201000003803 Inflammatory myofibroblastic tumor Diseases 0.000 description 2
• 206010070999 Intraductal papillary mucinous neoplasm Diseases 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 208000007766 Kaposi sarcoma Diseases 0.000 description 2
• 208000005102 Kashin-Beck Disease Diseases 0.000 description 2
• 101150103360 Kcnk4 gene Proteins 0.000 description 2
• 206010023347 Keratoacanthoma Diseases 0.000 description 2
• 108020003631 Kinetoplast DNA Proteins 0.000 description 2
• 208000028226 Krabbe disease Diseases 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• 201000005802 Landau-Kleffner Syndrome Diseases 0.000 description 2
• 208000006136 Leigh Disease Diseases 0.000 description 2
• 208000017507 Leigh syndrome Diseases 0.000 description 2
• 206010025421 Macule Diseases 0.000 description 2
• 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 2
• 208000001826 Marfan syndrome Diseases 0.000 description 2
• 208000005767 Megalencephaly Diseases 0.000 description 2
• 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 2
• 201000009906 Meningitis Diseases 0.000 description 2
• 208000008948 Menkes Kinky Hair Syndrome Diseases 0.000 description 2
• 208000012583 Menkes disease Diseases 0.000 description 2
• 206010027457 Metastases to liver Diseases 0.000 description 2
• 108700011259 MicroRNAs Proteins 0.000 description 2
• 208000019695 Migraine disease Diseases 0.000 description 2
• 108020005196 Mitochondrial DNA Proteins 0.000 description 2
• 201000002169 Mitochondrial myopathy Diseases 0.000 description 2
• 201000002983 Mobius syndrome Diseases 0.000 description 2
• 208000026072 Motor neurone disease Diseases 0.000 description 2
• 208000034578 Multiple myelomas Diseases 0.000 description 2
• 101100510267 Mus musculus Klf4 gene Proteins 0.000 description 2
• 101100134926 Mus musculus Olfr6 gene Proteins 0.000 description 2
• 101001094698 Mus musculus POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
• 101100257363 Mus musculus Sox2 gene Proteins 0.000 description 2
• 208000033835 Myelomonocytic Acute Leukemia Diseases 0.000 description 2
• 201000007224 Myeloproliferative neoplasm Diseases 0.000 description 2
• 201000002481 Myositis Diseases 0.000 description 2
• 208000001738 Nervous System Trauma Diseases 0.000 description 2
• 208000008457 Neurologic Manifestations Diseases 0.000 description 2
• 208000014060 Niemann-Pick disease Diseases 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• 208000008589 Obesity Diseases 0.000 description 2
• 206010030043 Ocular hypertension Diseases 0.000 description 2
• 241000243985 Onchocerca volvulus Species 0.000 description 2
• 206010030348 Open-Angle Glaucoma Diseases 0.000 description 2
• 206010053854 Opsoclonus myoclonus Diseases 0.000 description 2
• 206010031149 Osteitis Diseases 0.000 description 2
• 208000002804 Osteochondritis Diseases 0.000 description 2
• 206010031252 Osteomyelitis Diseases 0.000 description 2
• 208000001132 Osteoporosis Diseases 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 206010051686 Pachydermoperiostosis Diseases 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 2
• 208000004788 Pars Planitis Diseases 0.000 description 2
• 208000031839 Peripheral nerve sheath tumour malignant Diseases 0.000 description 2
• 208000031845 Pernicious anaemia Diseases 0.000 description 2
• 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 2
• 108091007412 Piwi-interacting RNA Proteins 0.000 description 2
• 208000000474 Poliomyelitis Diseases 0.000 description 2
• 206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
• 208000004550 Postoperative Pain Diseases 0.000 description 2
• 201000010769 Prader-Willi syndrome Diseases 0.000 description 2
• 206010057846 Primitive neuroectodermal tumour Diseases 0.000 description 2
• 208000024777 Prion disease Diseases 0.000 description 2
• 208000007932 Progeria Diseases 0.000 description 2
• 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 2
• 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 201000004681 Psoriasis Diseases 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 208000015634 Rectal Neoplasms Diseases 0.000 description 2
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
• 206010038848 Retinal detachment Diseases 0.000 description 2
• 208000006289 Rett Syndrome Diseases 0.000 description 2
• 201000007981 Reye syndrome Diseases 0.000 description 2
• 208000025747 Rheumatic disease Diseases 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 206010039710 Scleroderma Diseases 0.000 description 2
• 208000034189 Sclerosis Diseases 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 102000039471 Small Nuclear RNA Human genes 0.000 description 2
• 108020003224 Small Nucleolar RNA Proteins 0.000 description 2
• 102000042773 Small Nucleolar RNA Human genes 0.000 description 2
• 206010041067 Small cell lung cancer Diseases 0.000 description 2
• 201000010829 Spina bifida Diseases 0.000 description 2
• 208000006097 Spinal Dysraphism Diseases 0.000 description 2
• 208000003954 Spinal Muscular Atrophies of Childhood Diseases 0.000 description 2
• 208000020307 Spinal disease Diseases 0.000 description 2
• 208000006045 Spondylarthropathies Diseases 0.000 description 2
• 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 2
• 206010042265 Sturge-Weber Syndrome Diseases 0.000 description 2
• 206010042778 Syndactyly Diseases 0.000 description 2
• 201000009594 Systemic Scleroderma Diseases 0.000 description 2
• 201000008736 Systemic mastocytosis Diseases 0.000 description 2
• 101150034175 Syt10 gene Proteins 0.000 description 2
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 2
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 2
• 208000034799 Tauopathies Diseases 0.000 description 2
• 208000022292 Tay-Sachs disease Diseases 0.000 description 2
• 208000035954 Thomsen and Becker disease Diseases 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 208000000323 Tourette Syndrome Diseases 0.000 description 2
• 208000016620 Tourette disease Diseases 0.000 description 2
• 201000003379 Townes-Brocks syndrome Diseases 0.000 description 2
• 108020004566 Transfer RNA Proteins 0.000 description 2
• 208000032109 Transient ischaemic attack Diseases 0.000 description 2
• 102100033254 Tumor suppressor ARF Human genes 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 101150109071 UBC gene Proteins 0.000 description 2
• 201000006704 Ulcerative Colitis Diseases 0.000 description 2
• 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 2
• 208000036826 VIIth nerve paralysis Diseases 0.000 description 2
• 206010047115 Vasculitis Diseases 0.000 description 2
• 206010047531 Visual acuity reduced Diseases 0.000 description 2
• 201000006791 West syndrome Diseases 0.000 description 2
• 206010049644 Williams syndrome Diseases 0.000 description 2
• 241001492404 Woodchuck hepatitis virus Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000004308 accommodation Effects 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 230000009692 acute damage Effects 0.000 description 2
• 208000002552 acute disseminated encephalomyelitis Diseases 0.000 description 2
• 208000011912 acute myelomonocytic leukemia M4 Diseases 0.000 description 2
• 231100000403 acute toxicity Toxicity 0.000 description 2
• 230000007059 acute toxicity Effects 0.000 description 2
• 101150063416 add gene Proteins 0.000 description 2
• 208000030597 adult Refsum disease Diseases 0.000 description 2
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 2
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 2
• 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 150000001413 amino acids Chemical group 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 239000003816 antisense DNA Substances 0.000 description 2
• 208000021780 appendiceal neoplasm Diseases 0.000 description 2
• 206010003230 arteritis Diseases 0.000 description 2
• 206010003441 asbestosis Diseases 0.000 description 2
• 230000037444 atrophy Effects 0.000 description 2
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000002457 bidirectional effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 208000018339 bone inflammation disease Diseases 0.000 description 2
• 201000006431 brachial plexus neuropathy Diseases 0.000 description 2
• 201000006715 brachydactyly Diseases 0.000 description 2
• 201000009267 bronchiectasis Diseases 0.000 description 2
• 208000035269 cancer or benign tumor Diseases 0.000 description 2
• 208000003295 carpal tunnel syndrome Diseases 0.000 description 2
• 210000000845 cartilage Anatomy 0.000 description 2
• 230000032677 cell aging Effects 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 230000010094 cellular senescence Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• 208000006990 cholangiocarcinoma Diseases 0.000 description 2
• 208000007451 chronic bronchitis Diseases 0.000 description 2
• 201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 description 2
• 208000023738 chronic lymphocytic leukemia/small lymphocytic lymphoma Diseases 0.000 description 2
• 230000007882 cirrhosis Effects 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 201000007254 color blindness Diseases 0.000 description 2
• 210000000795 conjunctiva Anatomy 0.000 description 2
• 208000021921 corneal disease Diseases 0.000 description 2
• 201000000159 corneal neovascularization Diseases 0.000 description 2
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 2
• 208000002445 cystadenocarcinoma Diseases 0.000 description 2
• 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 206010013932 dyslexia Diseases 0.000 description 2
• 201000003079 ectropion Diseases 0.000 description 2
• 230000008995 epigenetic change Effects 0.000 description 2
• 206010015037 epilepsy Diseases 0.000 description 2
• 201000006517 essential tremor Diseases 0.000 description 2
• 201000010934 exostosis Diseases 0.000 description 2
• 210000003414 extremity Anatomy 0.000 description 2
• 208000024519 eye neoplasm Diseases 0.000 description 2
• 208000002980 facial hemiatrophy Diseases 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 238000002073 fluorescence micrograph Methods 0.000 description 2
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• 208000016354 hearing loss disease Diseases 0.000 description 2
• 201000011066 hemangioma Diseases 0.000 description 2
• 208000007475 hemolytic anemia Diseases 0.000 description 2
• 208000007386 hepatic encephalopathy Diseases 0.000 description 2
• 208000021995 hereditary motor and sensory neuropathy Diseases 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• 108010051779 histone H3 trimethyl Lys4 Proteins 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000007574 infarction Effects 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 208000036971 interstitial lung disease 2 Diseases 0.000 description 2
• 201000002313 intestinal cancer Diseases 0.000 description 2
• 230000009545 invasion Effects 0.000 description 2
• 210000000554 iris Anatomy 0.000 description 2
• 201000004614 iritis Diseases 0.000 description 2
• 201000010901 lateral sclerosis Diseases 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 108010074774 long-wavelength opsin Proteins 0.000 description 2
• 201000003265 lymphadenitis Diseases 0.000 description 2
• 201000004792 malaria Diseases 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• 230000006984 memory degeneration Effects 0.000 description 2
• 208000023060 memory loss Diseases 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 239000002679 microRNA Substances 0.000 description 2
• 229960003248 mifepristone Drugs 0.000 description 2
• VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 2
• 206010027599 migraine Diseases 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 208000012268 mitochondrial disease Diseases 0.000 description 2
• 201000005545 motor peripheral neuropathy Diseases 0.000 description 2
• 208000025113 myeloid leukemia Diseases 0.000 description 2
• 230000009826 neoplastic cell growth Effects 0.000 description 2
• 201000008026 nephroblastoma Diseases 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 208000029974 neurofibrosarcoma Diseases 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 201000001119 neuropathy Diseases 0.000 description 2
• 230000007823 neuropathy Effects 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• 201000008106 ocular cancer Diseases 0.000 description 2
• 201000002575 ocular melanoma Diseases 0.000 description 2
• 201000008968 osteosarcoma Diseases 0.000 description 2
• 201000002528 pancreatic cancer Diseases 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 210000000578 peripheral nerve Anatomy 0.000 description 2
• 210000001428 peripheral nervous system Anatomy 0.000 description 2
• 208000005026 persistent vegetative state Diseases 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 201000006292 polyarteritis nodosa Diseases 0.000 description 2
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 2
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 2
• 201000006652 primary hypertrophic osteoarthropathy Diseases 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 208000018329 progeroid syndrome Diseases 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 208000001381 pseudotumor cerebri Diseases 0.000 description 2
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 206010038038 rectal cancer Diseases 0.000 description 2
• 201000001275 rectum cancer Diseases 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 230000004264 retinal detachment Effects 0.000 description 2
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
• 108020004418 ribosomal RNA Proteins 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 201000000306 sarcoidosis Diseases 0.000 description 2
• 230000036573 scar formation Effects 0.000 description 2
• 208000010157 sclerosing cholangitis Diseases 0.000 description 2
• 208000002477 septooptic dysplasia Diseases 0.000 description 2
• 208000007056 sickle cell anemia Diseases 0.000 description 2
• 208000017520 skin disease Diseases 0.000 description 2
• 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 2
• 201000005671 spondyloarthropathy Diseases 0.000 description 2
• 231100000240 steatosis hepatitis Toxicity 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 208000011117 substance-related disease Diseases 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 230000010741 sumoylation Effects 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 206010042772 syncope Diseases 0.000 description 2
• 101150024821 tetO gene Proteins 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 230000000451 tissue damage Effects 0.000 description 2
• 231100000827 tissue damage Toxicity 0.000 description 2
• 210000004746 tooth root Anatomy 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 208000009174 transverse myelitis Diseases 0.000 description 2
• 208000006961 tropical spastic paraparesis Diseases 0.000 description 2
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
• 230000034512 ubiquitination Effects 0.000 description 2
• 238000010798 ubiquitination Methods 0.000 description 2
• 230000004304 visual acuity Effects 0.000 description 2
• FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
• NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• 102100032292 A disintegrin and metalloproteinase with thrombospondin motifs 17 Human genes 0.000 description 1
• 101150006401 ABHD17C gene Proteins 0.000 description 1
• 108091005674 ADAMTS17 Proteins 0.000 description 1
• 102000017908 ADRA1B Human genes 0.000 description 1
• 208000002618 Aarskog syndrome Diseases 0.000 description 1
• 208000033745 Aarskog-Scott syndrome Diseases 0.000 description 1
• 206010063429 Aase syndrome Diseases 0.000 description 1
• 206010000234 Abortion spontaneous Diseases 0.000 description 1
• 206010069408 Acanthamoeba keratitis Diseases 0.000 description 1
• 101500011733 Acipenser gueldenstaedtii Acipensin 5 Proteins 0.000 description 1
• 101710159080 Aconitate hydratase A Proteins 0.000 description 1
• 101710159078 Aconitate hydratase B Proteins 0.000 description 1
• 101150081849 Acot12 gene Proteins 0.000 description 1
• 206010052075 Acquired epileptic aphasia Diseases 0.000 description 1
• 201000010028 Acrocephalosyndactylia Diseases 0.000 description 1
• 206010000591 Acrochordon Diseases 0.000 description 1
• 206010000599 Acromegaly Diseases 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 102100034111 Activin receptor type-1 Human genes 0.000 description 1
• 208000007788 Acute Liver Failure Diseases 0.000 description 1
• 206010000804 Acute hepatic failure Diseases 0.000 description 1
• 208000005452 Acute intermittent porphyria Diseases 0.000 description 1
• 206010000830 Acute leukaemia Diseases 0.000 description 1
• 206010001197 Adenocarcinoma of the cervix Diseases 0.000 description 1
• 208000034246 Adenocarcinoma of the cervix uteri Diseases 0.000 description 1
• 208000036764 Adenocarcinoma of the esophagus Diseases 0.000 description 1
• 208000003200 Adenoma Diseases 0.000 description 1
• 102100031792 Adipogenin Human genes 0.000 description 1
• 208000005676 Adrenogenital syndrome Diseases 0.000 description 1
• 208000006888 Agnosia Diseases 0.000 description 1
• 241001047040 Agnosia Species 0.000 description 1
• 208000008811 Agoraphobia Diseases 0.000 description 1
• 201000002882 Agraphia Diseases 0.000 description 1
• 208000024341 Aicardi syndrome Diseases 0.000 description 1
• 206010001557 Albinism Diseases 0.000 description 1
• 208000028060 Albright disease Diseases 0.000 description 1
• 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
• 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
• 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 208000011403 Alexander disease Diseases 0.000 description 1
• 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
• 208000023434 Alpers-Huttenlocher syndrome Diseases 0.000 description 1
• 208000012791 Alpha-heavy chain disease Diseases 0.000 description 1
• 208000024985 Alport syndrome Diseases 0.000 description 1
• 108091023043 Alu Element Proteins 0.000 description 1
• 208000035939 Alveolitis allergic Diseases 0.000 description 1
• 208000031091 Amnestic disease Diseases 0.000 description 1
• 206010060937 Amniotic cavity infection Diseases 0.000 description 1
• 208000029197 Amphetamine-Related disease Diseases 0.000 description 1
• 206010002027 Amyotrophy Diseases 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 206010002198 Anaphylactic reaction Diseases 0.000 description 1
• 208000000058 Anaplasia Diseases 0.000 description 1
• 206010056292 Androgen-Insensitivity Syndrome Diseases 0.000 description 1
• 241000415078 Anemone hepatica Species 0.000 description 1
• 208000005598 Angioid Streaks Diseases 0.000 description 1
• 206010051810 Angiomyolipoma Diseases 0.000 description 1
• 208000009594 Animal Hepatitis Diseases 0.000 description 1
• 206010002650 Anorexia nervosa and bulimia Diseases 0.000 description 1
• 206010002660 Anoxia Diseases 0.000 description 1
• 241000976983 Anoxia Species 0.000 description 1
• 206010059199 Anterior chamber cleavage syndrome Diseases 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 101710081722 Antitrypsin Proteins 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 208000025490 Apert syndrome Diseases 0.000 description 1
• 208000032467 Aplastic anaemia Diseases 0.000 description 1
• 101150102415 Apob gene Proteins 0.000 description 1
• 206010003011 Appendicitis Diseases 0.000 description 1
• 206010003062 Apraxia Diseases 0.000 description 1
• 208000022316 Arachnoid cyst Diseases 0.000 description 1
• 241000180579 Arca Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 201000007978 Argyll Robertson pupil Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 208000022211 Arteriovenous Malformations Diseases 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 208000036640 Asperger disease Diseases 0.000 description 1
• 201000006062 Asperger syndrome Diseases 0.000 description 1
• 206010003487 Aspergilloma Diseases 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• 206010053622 Asplenia Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 102000007371 Ataxin-3 Human genes 0.000 description 1
• 101150064162 Atp2c2 gene Proteins 0.000 description 1
• 102100037293 Atrial natriuretic peptide-converting enzyme Human genes 0.000 description 1
• 101710133555 Atrial natriuretic peptide-converting enzyme Proteins 0.000 description 1
• 208000027448 Attention Deficit and Disruptive Behavior disease Diseases 0.000 description 1
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 208000010059 Axenfeld-Rieger syndrome Diseases 0.000 description 1
• 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 description 1
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 208000028564 B-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 208000029862 Barrett adenocarcinoma Diseases 0.000 description 1
• 206010062804 Basal cell naevus syndrome Diseases 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 201000000046 Beckwith-Wiedemann syndrome Diseases 0.000 description 1
• 208000009137 Behcet syndrome Diseases 0.000 description 1
• 208000020941 Benign concentric annular macular dystrophy Diseases 0.000 description 1
• 206010004265 Benign familial pemphigus Diseases 0.000 description 1
• 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
• 206010004485 Berylliosis Diseases 0.000 description 1
• 102100028164 Bestrophin-3 Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 208000003609 Bile Duct Adenoma Diseases 0.000 description 1
• 206010004593 Bile duct cancer Diseases 0.000 description 1
• 208000033932 Blackfan-Diamond anemia Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 201000004940 Bloch-Sulzberger syndrome Diseases 0.000 description 1
• 208000005692 Bloom Syndrome Diseases 0.000 description 1
• 208000020084 Bone disease Diseases 0.000 description 1
• 206010006074 Brachial plexus injury Diseases 0.000 description 1
• 208000004020 Brain Abscess Diseases 0.000 description 1
• 208000024806 Brain atrophy Diseases 0.000 description 1
• 208000021465 Brief psychotic disease Diseases 0.000 description 1
• 206010006448 Bronchiolitis Diseases 0.000 description 1
• 201000004813 Bronchopneumonia Diseases 0.000 description 1
• 102100025441 Brother of CDO Human genes 0.000 description 1
• 206010006491 Brown-Sequard syndrome Diseases 0.000 description 1
• 208000007257 Budd-Chiari syndrome Diseases 0.000 description 1
• 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
• 206010006811 Bursitis Diseases 0.000 description 1
• 101150052909 CCL2 gene Proteins 0.000 description 1
• 101150102665 CCL20 gene Proteins 0.000 description 1
• 101150011672 CCL9 gene Proteins 0.000 description 1
• 101150066577 CD14 gene Proteins 0.000 description 1
• 101150085381 CDC19 gene Proteins 0.000 description 1
• 101150060249 CHRM3 gene Proteins 0.000 description 1
• QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
• 101150000551 CRYAA gene Proteins 0.000 description 1
• 101150075266 CYP7A1 gene Proteins 0.000 description 1
• 101100017018 Caenorhabditis elegans him-14 gene Proteins 0.000 description 1
• 101100480861 Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) tdh gene Proteins 0.000 description 1
• 208000009903 Camurati-Engelmann Syndrome Diseases 0.000 description 1
• 208000013627 Camurati-Engelmann disease Diseases 0.000 description 1
• 208000022526 Canavan disease Diseases 0.000 description 1
• 101100447466 Candida albicans (strain WO-1) TDH1 gene Proteins 0.000 description 1
• 208000009458 Carcinoma in Situ Diseases 0.000 description 1
• 201000000274 Carcinosarcoma Diseases 0.000 description 1
• 208000031229 Cardiomyopathies Diseases 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 206010058892 Carnitine deficiency Diseases 0.000 description 1
• 108700005857 Carnitine palmitoyl transferase 1A deficiency Proteins 0.000 description 1
• 208000005359 Carnitine palmitoyl transferase 1A deficiency Diseases 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 102100024046 Cell adhesion molecule 3 Human genes 0.000 description 1
• 206010007882 Cellulitis Diseases 0.000 description 1
• 208000016615 Central areolar choroidal dystrophy Diseases 0.000 description 1
• 206010064012 Central pain syndrome Diseases 0.000 description 1
• 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
• 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241001608562 Chalazion Species 0.000 description 1
• 201000008992 Charcot-Marie-Tooth disease type 1B Diseases 0.000 description 1
• 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
• 208000018380 Chemical injury Diseases 0.000 description 1
• 206010008513 Child maltreatment syndrome Diseases 0.000 description 1
• 206010008583 Chloroma Diseases 0.000 description 1
• 108020004998 Chloroplast DNA Proteins 0.000 description 1
• 206010008617 Cholecystitis chronic Diseases 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• 206010008635 Cholestasis Diseases 0.000 description 1
• 201000005262 Chondroma Diseases 0.000 description 1
• 208000005243 Chondrosarcoma Diseases 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 208000008158 Chorioamnionitis Diseases 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 201000005072 Chorioretinal scar Diseases 0.000 description 1
• 208000033379 Chorioretinopathy Diseases 0.000 description 1
• 208000006597 Choroid Hemorrhage Diseases 0.000 description 1
• 206010008786 Choroidal haemorrhage Diseases 0.000 description 1
• 208000008515 Choroidal sclerosis Diseases 0.000 description 1
• 208000002691 Choroiditis Diseases 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
• 206010008909 Chronic Hepatitis Diseases 0.000 description 1
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
• 201000000915 Chronic Progressive External Ophthalmoplegia Diseases 0.000 description 1
• 208000023355 Chronic beryllium disease Diseases 0.000 description 1
• 101150058295 Cntn4 gene Proteins 0.000 description 1
• 208000021089 Coats disease Diseases 0.000 description 1
• 208000022497 Cocaine-Related disease Diseases 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 201000003101 Coloboma Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
• 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
• 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 description 1
• 208000027691 Conduct disease Diseases 0.000 description 1
• 208000032170 Congenital Abnormalities Diseases 0.000 description 1
• 208000008448 Congenital adrenal hyperplasia Diseases 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 206010062759 Congenital dyskeratosis Diseases 0.000 description 1
• 206010062344 Congenital musculoskeletal anomaly Diseases 0.000 description 1
• 206010052465 Congenital poikiloderma Diseases 0.000 description 1
• 206010010904 Convulsion Diseases 0.000 description 1
• 102000012437 Copper-Transporting ATPases Human genes 0.000 description 1
• 201000009343 Cornelia de Lange syndrome Diseases 0.000 description 1
• 208000011990 Corticobasal Degeneration Diseases 0.000 description 1
• 206010067380 Costello Syndrome Diseases 0.000 description 1
• 208000012609 Cowden disease Diseases 0.000 description 1
• 201000002847 Cowden syndrome Diseases 0.000 description 1
• 108091029430 CpG site Proteins 0.000 description 1
• 101150043206 Cracr2b gene Proteins 0.000 description 1
• 206010066946 Craniofacial dysostosis Diseases 0.000 description 1
• 208000001727 Craniofrontonasal dysplasia Diseases 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 101150078549 Crls1 gene Proteins 0.000 description 1
• 201000006526 Crouzon syndrome Diseases 0.000 description 1
• 102100024382 Cullin-associated NEDD8-dissociated protein 2 Human genes 0.000 description 1
• 101150079919 Cyp27a1 gene Proteins 0.000 description 1
• 206010011732 Cyst Diseases 0.000 description 1
• 201000005171 Cystadenoma Diseases 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 101150033773 DGKG gene Proteins 0.000 description 1
• 101150077941 DLK2 gene Proteins 0.000 description 1
• 230000030914 DNA methylation on adenine Effects 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 206010011841 Dacryoadenitis acquired Diseases 0.000 description 1
• 108010092160 Dactinomycin Proteins 0.000 description 1
• 201000003863 Dandy-Walker Syndrome Diseases 0.000 description 1
• 101100500437 Danio rerio dytn gene Proteins 0.000 description 1
• 101100465384 Danio rerio pvalb2 gene Proteins 0.000 description 1
• 101100521444 Danio rerio pvalb7 gene Proteins 0.000 description 1
• 208000003471 De Lange Syndrome Diseases 0.000 description 1
• 206010012218 Delirium Diseases 0.000 description 1
• 208000024254 Delusional disease Diseases 0.000 description 1
• 241001128004 Demodex Species 0.000 description 1
• 208000001490 Dengue Diseases 0.000 description 1
• 206010012310 Dengue fever Diseases 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 102100036912 Desmin Human genes 0.000 description 1
• 108010044052 Desmin Proteins 0.000 description 1
• 208000000398 DiGeorge Syndrome Diseases 0.000 description 1
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
• 208000010837 Diabetic eye disease Diseases 0.000 description 1
• 201000004449 Diamond-Blackfan anemia Diseases 0.000 description 1
• 201000003066 Diffuse Scleroderma Diseases 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 201000010374 Down Syndrome Diseases 0.000 description 1
• 101100510329 Drosophila melanogaster Pkc53E gene Proteins 0.000 description 1
• 208000001925 Dubowitz syndrome Diseases 0.000 description 1
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
• 206010013883 Dwarfism Diseases 0.000 description 1
• 108091035710 E-box Proteins 0.000 description 1
• 101150049876 EDN1 gene Proteins 0.000 description 1
• 101150001833 EDNRB gene Proteins 0.000 description 1
• 101150054336 EFEMP1 gene Proteins 0.000 description 1
• 101150114701 EPHX1 gene Proteins 0.000 description 1
• 206010071545 Early infantile epileptic encephalopathy with burst-suppression Diseases 0.000 description 1
• 208000030814 Eating disease Diseases 0.000 description 1
• UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
• 208000009366 Echinococcosis Diseases 0.000 description 1
• 201000002650 Ellis-van Creveld syndrome Diseases 0.000 description 1
• 206010049020 Encephalitis periaxialis diffusa Diseases 0.000 description 1
• 208000002403 Encephalocele Diseases 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 208000004145 Endometritis Diseases 0.000 description 1
• 208000004232 Enteritis Diseases 0.000 description 1
• 208000002460 Enteropathy-Associated T-Cell Lymphoma Diseases 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 206010014950 Eosinophilia Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 201000011275 Epicondylitis Diseases 0.000 description 1
• 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
• 241000909851 Epiphora Species 0.000 description 1
• 208000001351 Epiretinal Membrane Diseases 0.000 description 1
• 101150004694 Erbb4 gene Proteins 0.000 description 1
• 206010049466 Erythroblastosis Diseases 0.000 description 1
• 101100103045 Escherichia coli (strain K12) xapR gene Proteins 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 208000001692 Esotropia Diseases 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• 201000005538 Exotropia Diseases 0.000 description 1
• 208000007348 Experimental Liver Cirrhosis Diseases 0.000 description 1
• 206010015901 Exudative retinopathy Diseases 0.000 description 1
• 208000020564 Eye injury Diseases 0.000 description 1
• 206010015946 Eye irritation Diseases 0.000 description 1
• 206010015995 Eyelid ptosis Diseases 0.000 description 1
• 101150009958 FLT4 gene Proteins 0.000 description 1
• 101150066718 FMOD gene Proteins 0.000 description 1
• 208000024720 Fabry Disease Diseases 0.000 description 1
• 206010063006 Facial spasm Diseases 0.000 description 1
• 206010067141 Faciodigitogenital dysplasia Diseases 0.000 description 1
• 206010016207 Familial Mediterranean fever Diseases 0.000 description 1
• 208000037574 Familial benign chronic pemphigus Diseases 0.000 description 1
• 206010016228 Fasciitis Diseases 0.000 description 1
• 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
• 208000019454 Feeding and Eating disease Diseases 0.000 description 1
• 101150070880 Ffar4 gene Proteins 0.000 description 1
• 208000007300 Fibrolamellar hepatocellular carcinoma Diseases 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 208000004057 Focal Nodular Hyperplasia Diseases 0.000 description 1
• 208000001914 Fragile X syndrome Diseases 0.000 description 1
• 208000014260 Fungal keratitis Diseases 0.000 description 1
• 101150094690 GAL1 gene Proteins 0.000 description 1
• 101150038242 GAL10 gene Proteins 0.000 description 1
• 101150096192 GGT1 gene Proteins 0.000 description 1
• 101150099297 Gabrd gene Proteins 0.000 description 1
• 102100028501 Galanin peptides Human genes 0.000 description 1
• 102100024637 Galectin-10 Human genes 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 208000007882 Gastritis Diseases 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 102000013382 Gelatinases Human genes 0.000 description 1
• 108010026132 Gelatinases Proteins 0.000 description 1
• 208000011688 Generalised anxiety disease Diseases 0.000 description 1
• 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
• 208000007223 Gerstmann syndrome Diseases 0.000 description 1
• 208000002966 Giant Cell Tumor of Bone Diseases 0.000 description 1
• 101150080984 Gja5 gene Proteins 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 201000004299 Goldberg-Shprintzen syndrome Diseases 0.000 description 1
• 208000031995 Gorlin syndrome Diseases 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 208000009396 Group II Malformations of Cortical Development Diseases 0.000 description 1
• 208000023329 Gun shot wound Diseases 0.000 description 1
• 208000007698 Gyrate Atrophy Diseases 0.000 description 1
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
• 101150036925 HCN4 gene Proteins 0.000 description 1
• 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
• 208000027655 Hailey-Hailey disease Diseases 0.000 description 1
• 208000002927 Hamartoma Diseases 0.000 description 1
• 101150093815 Hcn3 gene Proteins 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 208000004095 Hemifacial Spasm Diseases 0.000 description 1
• 206010019463 Hemihypertrophy Diseases 0.000 description 1
• 208000018565 Hemochromatosis Diseases 0.000 description 1
• 208000032843 Hemorrhage Diseases 0.000 description 1
• 208000004751 Hepatic Echinococcosis Diseases 0.000 description 1
• 206010019646 Hepatic cyst Diseases 0.000 description 1
• 206010019663 Hepatic failure Diseases 0.000 description 1
• 206010019713 Hepatic vein thrombosis Diseases 0.000 description 1
• 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
• 208000003591 Hepatoerythropoietic Porphyria Diseases 0.000 description 1
• 208000003923 Hereditary Corneal Dystrophies Diseases 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 1
• 206010019899 Hereditary retinal dystrophy Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 206010063491 Herpes zoster oticus Diseases 0.000 description 1
• 108050005231 Histone H2A Proteins 0.000 description 1
• 102000017286 Histone H2A Human genes 0.000 description 1
• 101710103773 Histone H2B Proteins 0.000 description 1
• 102100021639 Histone H2B type 1-K Human genes 0.000 description 1
• 208000016619 Histrionic personality disease Diseases 0.000 description 1
• 102100028092 Homeobox protein Nkx-3.1 Human genes 0.000 description 1
• 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 1
• 101000775466 Homo sapiens Adipogenin Proteins 0.000 description 1
• 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
• 101000689698 Homo sapiens Alpha-1B adrenergic receptor Proteins 0.000 description 1
• 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
• 101100437786 Homo sapiens BOC gene Proteins 0.000 description 1
• 101000697366 Homo sapiens Bestrophin-3 Proteins 0.000 description 1
• 101100497358 Homo sapiens CRX gene Proteins 0.000 description 1
• 101000910449 Homo sapiens Cell adhesion molecule 3 Proteins 0.000 description 1
• 101000910263 Homo sapiens Cullin-associated NEDD8-dissociated protein 2 Proteins 0.000 description 1
• 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
• 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
• 101000578249 Homo sapiens Homeobox protein Nkx-3.1 Proteins 0.000 description 1
• 101000997017 Homo sapiens Neural retina-specific leucine zipper protein Proteins 0.000 description 1
• 101001134210 Homo sapiens Otogelin-like protein Proteins 0.000 description 1
• 101000572950 Homo sapiens POU domain, class 3, transcription factor 4 Proteins 0.000 description 1
• 101000665882 Homo sapiens Retinol-binding protein 4 Proteins 0.000 description 1
• 101000829506 Homo sapiens Rhodopsin kinase GRK1 Proteins 0.000 description 1
• 101000707241 Homo sapiens Seven in absentia homolog 3 Proteins 0.000 description 1
• 101000800463 Homo sapiens Transketolase Proteins 0.000 description 1
• 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 1
• 101150045775 Htr3a gene Proteins 0.000 description 1
• GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
• 208000037171 Hypercorticoidism Diseases 0.000 description 1
• 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
• 206010020675 Hypermetropia Diseases 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
• 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
• 101150042084 Ido2 gene Proteins 0.000 description 1
• 101150000070 Igfbp1 gene Proteins 0.000 description 1
• 101150065279 Il1rap gene Proteins 0.000 description 1
• 208000001718 Immediate Hypersensitivity Diseases 0.000 description 1
• 208000007866 Immunoproliferative Small Intestinal Disease Diseases 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 206010021531 Impetigo Diseases 0.000 description 1
• 206010021639 Incontinence Diseases 0.000 description 1
• 208000007031 Incontinentia pigmenti Diseases 0.000 description 1
• 208000008498 Infantile Refsum disease Diseases 0.000 description 1
• 208000035899 Infantile spasms syndrome Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 206010067917 Inflammatory myofibroblastic tumour Diseases 0.000 description 1
• 206010068331 Inflammatory pseudotumour Diseases 0.000 description 1
• 206010022158 Injury to brachial plexus due to birth trauma Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 208000005615 Interstitial Cystitis Diseases 0.000 description 1
• 208000018650 Intervertebral disc disease Diseases 0.000 description 1
• 201000008450 Intracranial aneurysm Diseases 0.000 description 1
• 206010022773 Intracranial pressure increased Diseases 0.000 description 1
• 206010061252 Intraocular melanoma Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 206010073098 Invasive papillary breast carcinoma Diseases 0.000 description 1
• 208000000209 Isaacs syndrome Diseases 0.000 description 1
• 208000009164 Islet Cell Adenoma Diseases 0.000 description 1
• 206010023126 Jaundice Diseases 0.000 description 1
• 206010023129 Jaundice cholestatic Diseases 0.000 description 1
• 208000012659 Joint disease Diseases 0.000 description 1
• 201000008645 Joubert syndrome Diseases 0.000 description 1
• 208000007367 Kabuki syndrome Diseases 0.000 description 1
• 101150090219 Kcnj11 gene Proteins 0.000 description 1
• 208000027747 Kennedy disease Diseases 0.000 description 1
• 206010062353 Keratitis fungal Diseases 0.000 description 1
• 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 208000017924 Klinefelter Syndrome Diseases 0.000 description 1
• 208000006541 Klippel-Feil syndrome Diseases 0.000 description 1
• 208000000588 Klippel-Trenaunay-Weber Syndrome Diseases 0.000 description 1
• 208000034642 Klippel-Trénaunay syndrome Diseases 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• 101150084247 LRFN2 gene Proteins 0.000 description 1
• 101150116826 LTC4S gene Proteins 0.000 description 1
• 208000005870 Lafora disease Diseases 0.000 description 1
• 208000014161 Lafora myoclonic epilepsy Diseases 0.000 description 1
• 201000010743 Lambert-Eaton myasthenic syndrome Diseases 0.000 description 1
• 206010050638 Langer-Giedion syndrome Diseases 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 201000008197 Laryngitis Diseases 0.000 description 1
• 208000020358 Learning disease Diseases 0.000 description 1
• 201000003533 Leber congenital amaurosis Diseases 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 201000006792 Lennox-Gastaut syndrome Diseases 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 208000009829 Lewy Body Disease Diseases 0.000 description 1
• 201000002832 Lewy body dementia Diseases 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 206010024612 Lipoma Diseases 0.000 description 1
• 206010048911 Lissencephaly Diseases 0.000 description 1
• 208000002404 Liver Cell Adenoma Diseases 0.000 description 1
• 206010024652 Liver abscess Diseases 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 101150105878 Lman1l gene Proteins 0.000 description 1
• 208000032923 Lobar pneumonia Diseases 0.000 description 1
• 208000002041 Loiasis Diseases 0.000 description 1
• 108020005198 Long Noncoding RNA Proteins 0.000 description 1
• 208000008930 Low Back Pain Diseases 0.000 description 1
• 208000010415 Low Vision Diseases 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
• 101150048659 MC5R gene Proteins 0.000 description 1
• 208000009564 MELAS Syndrome Diseases 0.000 description 1
• 201000009035 MERRF syndrome Diseases 0.000 description 1
• 101150104791 MYOC gene Proteins 0.000 description 1
• 208000002569 Machado-Joseph Disease Diseases 0.000 description 1
• 206010050183 Macrocephaly Diseases 0.000 description 1
• 208000004585 Macrostomia Diseases 0.000 description 1
• 208000001344 Macular Edema Diseases 0.000 description 1
• 206010025412 Macular dystrophy congenital Diseases 0.000 description 1
• 208000031471 Macular fibrosis Diseases 0.000 description 1
• 206010025415 Macular oedema Diseases 0.000 description 1
• 206010063185 Macular scar Diseases 0.000 description 1
• 208000035719 Maculopathy Diseases 0.000 description 1
• 208000032271 Malignant tumor of penis Diseases 0.000 description 1
• 208000003863 Marijuana Abuse Diseases 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 201000001853 McCune-Albright syndrome Diseases 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 208000009018 Medullary thyroid cancer Diseases 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 201000002571 Melkersson-Rosenthal syndrome Diseases 0.000 description 1
• 208000025917 Melnick-Needles syndrome Diseases 0.000 description 1
• 208000024556 Mendelian disease Diseases 0.000 description 1
• 208000019255 Menstrual disease Diseases 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 208000029725 Metabolic bone disease Diseases 0.000 description 1
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
• 206010027439 Metal poisoning Diseases 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 206010063341 Metamorphopsia Diseases 0.000 description 1
• 208000009795 Microphthalmos Diseases 0.000 description 1
• 108091092878 Microsatellite Proteins 0.000 description 1
• 206010059396 Mitochondrial DNA depletion Diseases 0.000 description 1
• 206010058799 Mitochondrial encephalomyopathy Diseases 0.000 description 1
• 208000014844 Mitochondrial neurogastrointestinal encephalomyopathy Diseases 0.000 description 1
• 208000003250 Mixed connective tissue disease Diseases 0.000 description 1
• 206010027802 Moebius II syndrome Diseases 0.000 description 1
• 208000034167 Moebius syndrome Diseases 0.000 description 1
• 208000010190 Monoclonal Gammopathy of Undetermined Significance Diseases 0.000 description 1
• 206010069681 Monomelic amyotrophy Diseases 0.000 description 1
• 208000019022 Mood disease Diseases 0.000 description 1
• 208000003445 Mouth Neoplasms Diseases 0.000 description 1
• 208000016285 Movement disease Diseases 0.000 description 1
• 208000009433 Moyamoya Disease Diseases 0.000 description 1
• 208000012799 Mu-heavy chain disease Diseases 0.000 description 1
• 208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
• 101150094183 Mug1 gene Proteins 0.000 description 1
• 208000005314 Multi-Infarct Dementia Diseases 0.000 description 1
• 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 description 1
• 208000006670 Multiple fractures Diseases 0.000 description 1
• 101100161750 Mus musculus Acot10 gene Proteins 0.000 description 1
• 101100438656 Mus musculus Ccdc162 gene Proteins 0.000 description 1
• 101100384852 Mus musculus Col26a1 gene Proteins 0.000 description 1
• 101100500439 Mus musculus Dytn gene Proteins 0.000 description 1
• 101100015215 Mus musculus Galnt15 gene Proteins 0.000 description 1
• 101100393013 Mus musculus Galnt18 gene Proteins 0.000 description 1
• 101100393523 Mus musculus Grid2ip gene Proteins 0.000 description 1
• 101100123336 Mus musculus H2ab1 gene Proteins 0.000 description 1
• 101100017006 Mus musculus Hhatl gene Proteins 0.000 description 1
• 101100011750 Mus musculus Hsp90b1 gene Proteins 0.000 description 1
• 101100397158 Mus musculus Il1rapl2 gene Proteins 0.000 description 1
• 101100341826 Mus musculus Kbtbd12 gene Proteins 0.000 description 1
• 101100403102 Mus musculus Mucl2 gene Proteins 0.000 description 1
• 101100519068 Mus musculus Pcdhb18 gene Proteins 0.000 description 1
• 101100083462 Mus musculus Pkhd1l1 gene Proteins 0.000 description 1
• 101100465040 Mus musculus Prickle2 gene Proteins 0.000 description 1
• 101100523830 Mus musculus Rbpms gene Proteins 0.000 description 1
• 101100533640 Mus musculus Slitrk3 gene Proteins 0.000 description 1
• 101100042839 Mus musculus Smok2a gene Proteins 0.000 description 1
• 101100370010 Mus musculus Tomm20l gene Proteins 0.000 description 1
• 101100261228 Mus musculus Trcg1 gene Proteins 0.000 description 1
• 101100048299 Mus musculus Ugt1a6 gene Proteins 0.000 description 1
• 101100101335 Mus musculus Usp17la gene Proteins 0.000 description 1
• 101100268212 Mus musculus Znf608 gene Proteins 0.000 description 1
• 208000002231 Muscle Neoplasms Diseases 0.000 description 1
• 208000008238 Muscle Spasticity Diseases 0.000 description 1
• 208000029578 Muscle disease Diseases 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• 206010028372 Muscular weakness Diseases 0.000 description 1
• 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
• 102100026784 Myelin proteolipid protein Human genes 0.000 description 1
• 208000003926 Myelitis Diseases 0.000 description 1
• 206010028570 Myelopathy Diseases 0.000 description 1
• 208000009525 Myocarditis Diseases 0.000 description 1
• 208000036572 Myoclonic epilepsy Diseases 0.000 description 1
• 206010069825 Myoclonic epilepsy and ragged-red fibres Diseases 0.000 description 1
• 208000002033 Myoclonus Diseases 0.000 description 1
• 201000004458 Myoma Diseases 0.000 description 1
• 201000009623 Myopathy Diseases 0.000 description 1
• 240000001307 Myosotis scorpioides Species 0.000 description 1
• 206010061533 Myotonia Diseases 0.000 description 1
• 206010068871 Myotonic dystrophy Diseases 0.000 description 1
• 208000000175 Nail-Patella Syndrome Diseases 0.000 description 1
• 208000027120 Narcissistic personality disease Diseases 0.000 description 1
• 206010028836 Neck pain Diseases 0.000 description 1
• 206010051606 Necrotising colitis Diseases 0.000 description 1
• 206010028885 Necrotising fasciitis Diseases 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 201000004404 Neurofibroma Diseases 0.000 description 1
• 201000005625 Neuroleptic malignant syndrome Diseases 0.000 description 1
• 206010072359 Neuromyotonia Diseases 0.000 description 1
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 1
• 101100234604 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ace-8 gene Proteins 0.000 description 1
• 101150026055 Ngfr gene Proteins 0.000 description 1
• 206010057852 Nicotine dependence Diseases 0.000 description 1
• 208000001140 Night Blindness Diseases 0.000 description 1
• 206010029461 Nodal marginal zone B-cell lymphomas Diseases 0.000 description 1
• 206010029748 Noonan syndrome Diseases 0.000 description 1
• 206010067013 Normal tension glaucoma Diseases 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 208000020265 O'Sullivan-McLeod syndrome Diseases 0.000 description 1
• 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
• 201000005267 Obstructive Jaundice Diseases 0.000 description 1
• 206010068106 Occipital neuralgia Diseases 0.000 description 1
• 108010068425 Octamer Transcription Factor-3 Proteins 0.000 description 1
• 102000002584 Octamer Transcription Factor-3 Human genes 0.000 description 1
• 206010030137 Oesophageal adenocarcinoma Diseases 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 208000026251 Opioid-Related disease Diseases 0.000 description 1
• 208000003435 Optic Neuritis Diseases 0.000 description 1
• 208000030768 Optic nerve injury Diseases 0.000 description 1
• 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
• 206010069350 Osmotic demyelination syndrome Diseases 0.000 description 1
• 208000000035 Osteochondroma Diseases 0.000 description 1
• 206010031240 Osteodystrophy Diseases 0.000 description 1
• 206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
• 208000003076 Osteolysis Diseases 0.000 description 1
• 206010031264 Osteonecrosis Diseases 0.000 description 1
• 206010049088 Osteopenia Diseases 0.000 description 1
• 208000008558 Osteophyte Diseases 0.000 description 1
• 201000000023 Osteosclerosis Diseases 0.000 description 1
• 208000005141 Otitis Diseases 0.000 description 1
• 102100034206 Otogelin-like protein Human genes 0.000 description 1
• 201000010810 Otospondylomegaepiphyseal dysplasia Diseases 0.000 description 1
• 101150059463 P2RY12 gene Proteins 0.000 description 1
• 101150018565 POGLUT3 gene Proteins 0.000 description 1
• 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 1
• 101150028973 PVALB gene Proteins 0.000 description 1
• 101150093629 PYK1 gene Proteins 0.000 description 1
• 208000017459 Paget disease of the penis Diseases 0.000 description 1
• 208000025610 Paget disease of the vulva Diseases 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 206010033645 Pancreatitis Diseases 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 208000030601 Parasitic Liver disease Diseases 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 206010034038 Parotitis Diseases 0.000 description 1
• 208000034038 Pathologic Neovascularization Diseases 0.000 description 1
• 201000004602 Peliosis Hepatis Diseases 0.000 description 1
• 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 201000011152 Pemphigus Diseases 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 208000004843 Pendred Syndrome Diseases 0.000 description 1
• 208000002471 Penile Neoplasms Diseases 0.000 description 1
• 206010034299 Penile cancer Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000027190 Peripheral T-cell lymphomas Diseases 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 208000012202 Pervasive developmental disease Diseases 0.000 description 1
• 208000004983 Phantom Limb Diseases 0.000 description 1
• 206010056238 Phantom pain Diseases 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• 201000007100 Pharyngitis Diseases 0.000 description 1
• 201000011252 Phenylketonuria Diseases 0.000 description 1
• 206010034912 Phobia Diseases 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 206010034944 Photokeratitis Diseases 0.000 description 1
• 208000000609 Pick Disease of the Brain Diseases 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 208000007720 Plasma Cell Granuloma Diseases 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 206010035742 Pneumonitis Diseases 0.000 description 1
• 208000008601 Polycythemia Diseases 0.000 description 1
• 206010036172 Porencephaly Diseases 0.000 description 1
• 201000010273 Porphyria Cutanea Tarda Diseases 0.000 description 1
• 206010036182 Porphyria acute Diseases 0.000 description 1
• 206010036186 Porphyria non-acute Diseases 0.000 description 1
• 208000003971 Posterior uveitis Diseases 0.000 description 1
• 208000010366 Postpoliomyelitis syndrome Diseases 0.000 description 1
• 101150015197 Pou3f4 gene Proteins 0.000 description 1
• 206010036524 Precursor B-lymphoblastic lymphomas Diseases 0.000 description 1
• 208000005107 Premature Birth Diseases 0.000 description 1
• 206010036618 Premenstrual syndrome Diseases 0.000 description 1
• 208000032319 Primary lateral sclerosis Diseases 0.000 description 1
• 206010036774 Proctitis Diseases 0.000 description 1
• 206010036802 Progressive external ophthalmoplegia Diseases 0.000 description 1
• 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 description 1
• 208000003251 Pruritus Diseases 0.000 description 1
• 201000002154 Pterygium Diseases 0.000 description 1
• 208000010378 Pulmonary Embolism Diseases 0.000 description 1
• 206010037538 Pupils unequal Diseases 0.000 description 1
• 206010037549 Purpura Diseases 0.000 description 1
• 206010037596 Pyelonephritis Diseases 0.000 description 1
• 101150026799 QSOX1 gene Proteins 0.000 description 1
• 102000044126 RNA-Binding Proteins Human genes 0.000 description 1
• 101710105008 RNA-binding protein Proteins 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 206010037779 Radiculopathy Diseases 0.000 description 1
• 208000032831 Ramsay Hunt syndrome Diseases 0.000 description 1
• 206010071141 Rasmussen encephalitis Diseases 0.000 description 1
• 208000004160 Rasmussen subacute encephalitis Diseases 0.000 description 1
• 101100001330 Rattus norvegicus Akr1c15 gene Proteins 0.000 description 1
• 101100135288 Rattus norvegicus P2rx5 gene Proteins 0.000 description 1
• 101100533701 Rattus norvegicus Smad1 gene Proteins 0.000 description 1
• 101150103025 Rcn3 gene Proteins 0.000 description 1
• 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 description 1
• 208000033464 Reiter syndrome Diseases 0.000 description 1
• 208000001647 Renal Insufficiency Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000006265 Renal cell carcinoma Diseases 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 206010063837 Reperfusion injury Diseases 0.000 description 1
• 206010038584 Repetitive strain injury Diseases 0.000 description 1
• 108010034634 Repressor Proteins Proteins 0.000 description 1
• 102000009661 Repressor Proteins Human genes 0.000 description 1
• 206010068956 Respiratory tract inflammation Diseases 0.000 description 1
• 208000005793 Restless legs syndrome Diseases 0.000 description 1
• 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 102100038246 Retinol-binding protein 4 Human genes 0.000 description 1
• 206010038923 Retinopathy Diseases 0.000 description 1
• 206010038926 Retinopathy hypertensive Diseases 0.000 description 1
• 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
• 206010038934 Retinopathy proliferative Diseases 0.000 description 1
• 208000032458 Retinopathy solar Diseases 0.000 description 1
• 206010039020 Rhabdomyolysis Diseases 0.000 description 1
• 101150107345 Rhag gene Proteins 0.000 description 1
• 102100040756 Rhodopsin Human genes 0.000 description 1
• 108090000820 Rhodopsin Proteins 0.000 description 1
• 208000000791 Rothmund-Thomson syndrome Diseases 0.000 description 1
• 101150049961 SLC2A5 gene Proteins 0.000 description 1
• 102000005635 SOXB1 Transcription Factors Human genes 0.000 description 1
• 108010045179 SOXB1 Transcription Factors Proteins 0.000 description 1
• 101150105785 SPON2 gene Proteins 0.000 description 1
• 101150036097 ST3GAL3 gene Proteins 0.000 description 1
• 101150027943 STC1 gene Proteins 0.000 description 1
• 101150088335 STC2 gene Proteins 0.000 description 1
• 101150008680 SYNDIG1 gene Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 208000007893 Salpingitis Diseases 0.000 description 1
• 208000021811 Sandhoff disease Diseases 0.000 description 1
• 108020004487 Satellite DNA Proteins 0.000 description 1
• 101150083648 Sav1 gene Proteins 0.000 description 1
• 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
• 208000021235 Schilder disease Diseases 0.000 description 1
• 208000000729 Schizencephaly Diseases 0.000 description 1
• 208000030988 Schizoid Personality disease Diseases 0.000 description 1
• 208000020186 Schizophreniform disease Diseases 0.000 description 1
• 101100296591 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pck2 gene Proteins 0.000 description 1
• 208000024791 Schizotypal Personality disease Diseases 0.000 description 1
• 208000006938 Schwannomatosis Diseases 0.000 description 1
• 208000018675 Schwartz-Jampel syndrome Diseases 0.000 description 1
• 206010039705 Scleritis Diseases 0.000 description 1
• 206010039729 Scotoma Diseases 0.000 description 1
• 206010048810 Sebaceous hyperplasia Diseases 0.000 description 1
• 201000006783 Seckel syndrome Diseases 0.000 description 1
• 201000010208 Seminoma Diseases 0.000 description 1
• 208000000810 Separation Anxiety Diseases 0.000 description 1
• 208000033995 Septo-optic dysplasia spectrum Diseases 0.000 description 1
• 102100031749 Seven in absentia homolog 3 Human genes 0.000 description 1
• 208000009359 Sezary Syndrome Diseases 0.000 description 1
• 208000021388 Sezary disease Diseases 0.000 description 1
• 208000002108 Shaken Baby Syndrome Diseases 0.000 description 1
• 208000019568 Shared Paranoid disease Diseases 0.000 description 1
• 208000028810 Shared psychotic disease Diseases 0.000 description 1
• 108091061750 Signal recognition particle RNA Proteins 0.000 description 1
• 201000010001 Silicosis Diseases 0.000 description 1
• 206010072610 Skeletal dysplasia Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 206010040954 Skin wrinkling Diseases 0.000 description 1
• 101150009088 Slc10a5 gene Proteins 0.000 description 1
• 101150103054 Slc12a4 gene Proteins 0.000 description 1
• 101150026500 Slc4a4 gene Proteins 0.000 description 1
• 101150028423 Slc6a4 gene Proteins 0.000 description 1
• 108020003562 Small Cytoplasmic RNA Proteins 0.000 description 1
• 108091027967 Small hairpin RNA Proteins 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 206010041250 Social phobia Diseases 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 206010064387 Sotos' syndrome Diseases 0.000 description 1
• 206010041415 Spastic paralysis Diseases 0.000 description 1
• 208000029033 Spinal Cord disease Diseases 0.000 description 1
• 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
• 208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 1
• 208000019229 Spleen disease Diseases 0.000 description 1
• 208000000277 Splenic Neoplasms Diseases 0.000 description 1
• 108020003213 Spliced Leader RNA Proteins 0.000 description 1
• 201000002661 Spondylitis Diseases 0.000 description 1
• 101150038447 Sstr2 gene Proteins 0.000 description 1
• 101150100226 Sstr3 gene Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 208000010513 Stupor Diseases 0.000 description 1
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
• 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
• 208000010502 Subcutaneous panniculitis-like T-cell lymphoma Diseases 0.000 description 1
• 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
• 208000027522 Sydenham chorea Diseases 0.000 description 1
• 206010042742 Sympathetic ophthalmia Diseases 0.000 description 1
• 206010042928 Syringomyelia Diseases 0.000 description 1
• 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 description 1
• 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 1
• 206010042971 T-cell lymphoma Diseases 0.000 description 1
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 101150000543 TMEM132A gene Proteins 0.000 description 1
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 1
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
• 101150047985 TRDN gene Proteins 0.000 description 1
• 101150098315 TRPV4 gene Proteins 0.000 description 1
• 208000001163 Tangier disease Diseases 0.000 description 1
• 206010043118 Tardive Dyskinesia Diseases 0.000 description 1
• 101150011805 Tcaf3 gene Proteins 0.000 description 1
• 108091046869 Telomeric non-coding RNA Proteins 0.000 description 1
• 208000000491 Tendinopathy Diseases 0.000 description 1
• 206010043255 Tendonitis Diseases 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 208000003217 Tetany Diseases 0.000 description 1
• 208000002903 Thalassemia Diseases 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 206010043515 Throat cancer Diseases 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 description 1
• 208000031789 Thygeson superficial punctate keratitis Diseases 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 101150075360 Tmem132d gene Proteins 0.000 description 1
• 208000025569 Tobacco Use disease Diseases 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 230000010632 Transcription Factor Activity Effects 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108050000630 Transcription factor SOX-2 Proteins 0.000 description 1
• 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
• 208000003441 Transfusion reaction Diseases 0.000 description 1
• 208000031674 Traumatic Acute Stress disease Diseases 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 208000035378 Trichorhinophalangeal syndrome type 2 Diseases 0.000 description 1
• 102100033598 Triosephosphate isomerase Human genes 0.000 description 1
• 206010044696 Tropical spastic paresis Diseases 0.000 description 1
• 101150099990 Trpc4 gene Proteins 0.000 description 1
• 208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• 208000026928 Turner syndrome Diseases 0.000 description 1
• 206010045240 Type I hypersensitivity Diseases 0.000 description 1
• 206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
• 208000037386 Typhoid Diseases 0.000 description 1
• 206010064996 Ulcerative keratitis Diseases 0.000 description 1
• 101150033545 Unc5b gene Proteins 0.000 description 1
• 206010046298 Upper motor neurone lesion Diseases 0.000 description 1
• 206010046431 Urethral cancer Diseases 0.000 description 1
• 206010046458 Urethral neoplasms Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000014769 Usher Syndromes Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000006374 Uterine Cervicitis Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 201000005969 Uveal melanoma Diseases 0.000 description 1
• 101150004676 VGF gene Proteins 0.000 description 1
• 206010046914 Vaginal infection Diseases 0.000 description 1
• 201000008100 Vaginitis Diseases 0.000 description 1
• 206010046996 Varicose vein Diseases 0.000 description 1
• 102000016663 Vascular Endothelial Growth Factor Receptor-3 Human genes 0.000 description 1
• 208000006288 Vascular Tissue Neoplasms Diseases 0.000 description 1
• 206010063661 Vascular encephalopathy Diseases 0.000 description 1
• 206010047097 Vascular purpura Diseases 0.000 description 1
• 206010047124 Vasculitis necrotising Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 208000014070 Vestibular schwannoma Diseases 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 208000037084 Viral Human Hepatitis Diseases 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 206010047513 Vision blurred Diseases 0.000 description 1
• 206010047571 Visual impairment Diseases 0.000 description 1
• 208000034699 Vitreous floaters Diseases 0.000 description 1
• 208000025749 Vogt-Koyanagi-Harada disease Diseases 0.000 description 1
• 208000034705 Vogt-Koyanagi-Harada syndrome Diseases 0.000 description 1
• 241000282485 Vulpes vulpes Species 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 208000026724 Waardenburg syndrome Diseases 0.000 description 1
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
• 208000035562 Wallenberg syndrome Diseases 0.000 description 1
• 201000003790 Weaver syndrome Diseases 0.000 description 1
• 206010053692 Wound complication Diseases 0.000 description 1
• 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
• 206010048211 Xanthelasma Diseases 0.000 description 1
• 101100485097 Xenopus laevis wnt11b gene Proteins 0.000 description 1
• 206010048218 Xeroderma Diseases 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 108010084455 Zeocin Proteins 0.000 description 1
• 108091007916 Zinc finger transcription factors Proteins 0.000 description 1
• 102000038627 Zinc finger transcription factors Human genes 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 201000000761 achromatopsia Diseases 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 208000004064 acoustic neuroma Diseases 0.000 description 1
• 201000007047 acrodysostosis Diseases 0.000 description 1
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
• 231100000836 acute liver failure Toxicity 0.000 description 1
• 208000005298 acute pain Diseases 0.000 description 1
• 201000010275 acute porphyria Diseases 0.000 description 1
• 208000026345 acute stress disease Diseases 0.000 description 1
• 208000036676 acute undifferentiated leukemia Diseases 0.000 description 1
• 208000012826 adjustment disease Diseases 0.000 description 1
• 201000005188 adrenal gland cancer Diseases 0.000 description 1
• 201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
• 208000024447 adrenal gland neoplasm Diseases 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 206010064930 age-related macular degeneration Diseases 0.000 description 1
• 208000038018 age-related macular disease Diseases 0.000 description 1
• 201000007930 alcohol dependence Diseases 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
• 208000002353 alcoholic hepatitis Diseases 0.000 description 1
• 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
• 206010001689 alkaptonuria Diseases 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 208000025751 alpha chain disease Diseases 0.000 description 1
• UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 208000011916 alternating hemiplegia Diseases 0.000 description 1
• 230000006986 amnesia Effects 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 206010002320 anencephaly Diseases 0.000 description 1
• 206010002449 angioimmunoblastic T-cell lymphoma Diseases 0.000 description 1
• 208000000252 angiomatosis Diseases 0.000 description 1
• 208000012948 angioosteohypertrophic syndrome Diseases 0.000 description 1
• 208000008303 aniridia Diseases 0.000 description 1
• 208000001239 anisocoria Diseases 0.000 description 1
• 206010002537 anisometropia Diseases 0.000 description 1
• 101150111716 ankrd1 gene Proteins 0.000 description 1
• 230000007953 anoxia Effects 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001475 anti-trypsic effect Effects 0.000 description 1
• 208000037908 antibody-mediated disorder Diseases 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 208000024823 antisocial personality disease Diseases 0.000 description 1
• 201000011165 anus cancer Diseases 0.000 description 1
• 201000007201 aphasia Diseases 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 206010003074 arachnoiditis Diseases 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000009697 arginine Nutrition 0.000 description 1
• 230000006217 arginine-methylation Effects 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 230000005744 arteriovenous malformation Effects 0.000 description 1
• 230000002917 arthritic effect Effects 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 230000001977 ataxic effect Effects 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
• 208000029560 autism spectrum disease Diseases 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 210000003403 autonomic nervous system Anatomy 0.000 description 1
• 208000031375 autosomal dominant myotonia congenita Diseases 0.000 description 1
• 208000021033 autosomal dominant polycystic liver disease Diseases 0.000 description 1
• 201000003639 autosomal recessive cerebellar ataxia Diseases 0.000 description 1
• 208000022804 avoidant personality disease Diseases 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 238000003287 bathing Methods 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 210000000013 bile duct Anatomy 0.000 description 1
• 208000037512 bile duct cyst Diseases 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 208000028683 bipolar I disease Diseases 0.000 description 1
• 230000007698 birth defect Effects 0.000 description 1
• 229930189065 blasticidin Natural products 0.000 description 1
• 208000034158 bleeding Diseases 0.000 description 1
• 230000000740 bleeding effect Effects 0.000 description 1
• 206010005159 blepharospasm Diseases 0.000 description 1
• 230000000744 blepharospasm Effects 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 208000016738 bone Paget disease Diseases 0.000 description 1
• 208000015322 bone marrow disease Diseases 0.000 description 1
• 208000030963 borderline personality disease Diseases 0.000 description 1
• 108010006025 bovine growth hormone Proteins 0.000 description 1
• 208000021138 brain aneurysm Diseases 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• 210000000133 brain stem Anatomy 0.000 description 1
• 201000008274 breast adenocarcinoma Diseases 0.000 description 1
• 201000000135 breast papillary carcinoma Diseases 0.000 description 1
• 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
• 206010006475 bronchopulmonary dysplasia Diseases 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 201000001843 cannabis dependence Diseases 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 229960003669 carbenicillin Drugs 0.000 description 1
• FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
• 201000004010 carnitine palmitoyltransferase I deficiency Diseases 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000006369 cell cycle progression Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 208000009885 central pontine myelinolysis Diseases 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 206010008129 cerebral palsy Diseases 0.000 description 1
• 201000006662 cervical adenocarcinoma Diseases 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 206010008323 cervicitis Diseases 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 208000010575 cherry hemangioma Diseases 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 208000003167 cholangitis Diseases 0.000 description 1
• 201000001352 cholecystitis Diseases 0.000 description 1
• 201000001173 choledochal cyst Diseases 0.000 description 1
• 201000001883 cholelithiasis Diseases 0.000 description 1
• 231100000359 cholestasis Toxicity 0.000 description 1
• 230000007870 cholestasis Effects 0.000 description 1
• 208000003571 choroideremia Diseases 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 201000010903 chronic neutrophilic leukemia Diseases 0.000 description 1
• 210000004240 ciliary body Anatomy 0.000 description 1
• 206010009259 cleft lip Diseases 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000008045 co-localization Effects 0.000 description 1
• 201000006145 cocaine dependence Diseases 0.000 description 1
• 230000006999 cognitive decline Effects 0.000 description 1
• 208000010877 cognitive disease Diseases 0.000 description 1
• 208000017419 commissural facial cleft Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 108700006372 cone rod homeobox Proteins 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 201000010918 connective tissue cancer Diseases 0.000 description 1
• 239000005289 controlled pore glass Substances 0.000 description 1
• 206010011005 corneal dystrophy Diseases 0.000 description 1
• 201000007717 corneal ulcer Diseases 0.000 description 1
• 210000000877 corpus callosum Anatomy 0.000 description 1
• 210000003792 cranial nerve Anatomy 0.000 description 1
• 201000003652 craniofrontonasal syndrome Diseases 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 101150020879 cybrd1 gene Proteins 0.000 description 1
• 208000026725 cyclothymic disease Diseases 0.000 description 1
• 201000003146 cystitis Diseases 0.000 description 1
• 230000002380 cytological effect Effects 0.000 description 1
• 201000004400 dacryoadenitis Diseases 0.000 description 1
• 229960000640 dactinomycin Drugs 0.000 description 1
• 231100000895 deafness Toxicity 0.000 description 1
• 230000032459 dedifferentiation Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000017858 demethylation Effects 0.000 description 1
• 238000010520 demethylation reaction Methods 0.000 description 1
• 238000005115 demineralization Methods 0.000 description 1
• 230000002328 demineralizing effect Effects 0.000 description 1
• 208000025729 dengue disease Diseases 0.000 description 1
• 208000030964 dependent personality disease Diseases 0.000 description 1
• 230000003831 deregulation Effects 0.000 description 1
• 210000005045 desmin Anatomy 0.000 description 1
• 201000009803 desquamative interstitial pneumonia Diseases 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 201000007394 diastrophic dysplasia Diseases 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 235000014632 disordered eating Nutrition 0.000 description 1
• 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 201000008865 drug-induced hepatitis Diseases 0.000 description 1
• 208000019479 dysautonomia Diseases 0.000 description 1
• 206010058319 dysgraphia Diseases 0.000 description 1
• 208000009356 dyskeratosis congenita Diseases 0.000 description 1
• 230000001544 dysphoric effect Effects 0.000 description 1
• 208000024732 dysthymic disease Diseases 0.000 description 1
• 208000010118 dystonia Diseases 0.000 description 1
• 208000019258 ear infection Diseases 0.000 description 1
• UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
• 208000002169 ectodermal dysplasia Diseases 0.000 description 1
• 208000031068 ectodermal dysplasia syndrome Diseases 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 206010014665 endocarditis Diseases 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 208000010227 enterocolitis Diseases 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 208000037828 epithelial carcinoma Diseases 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 208000028653 esophageal adenocarcinoma Diseases 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 208000001936 exophthalmos Diseases 0.000 description 1
• 201000001155 extrinsic allergic alveolitis Diseases 0.000 description 1
• 210000000744 eyelid Anatomy 0.000 description 1
• 208000012043 faciodigitogenital syndrome Diseases 0.000 description 1
• 201000001386 familial hypercholesterolemia Diseases 0.000 description 1
• 208000006275 fascioliasis Diseases 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 201000003444 follicular lymphoma Diseases 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 201000010175 gallbladder cancer Diseases 0.000 description 1
• 208000001130 gallstones Diseases 0.000 description 1
• 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 208000029364 generalized anxiety disease Diseases 0.000 description 1
• 230000004077 genetic alteration Effects 0.000 description 1
• 231100000118 genetic alteration Toxicity 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 201000011349 geniculate herpes zoster Diseases 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 201000003115 germ cell cancer Diseases 0.000 description 1
• 208000004104 gestational diabetes Diseases 0.000 description 1
• 208000007565 gingivitis Diseases 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 208000005594 glucose-galactose malabsorption Diseases 0.000 description 1
• 208000015362 glutaric aciduria Diseases 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 201000007192 granulomatous hepatitis Diseases 0.000 description 1
• 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 description 1
• 230000003676 hair loss Effects 0.000 description 1
• 201000006138 hallucinogen dependence Diseases 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 230000010370 hearing loss Effects 0.000 description 1
• 231100000888 hearing loss Toxicity 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 201000002222 hemangioblastoma Diseases 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 230000002949 hemolytic effect Effects 0.000 description 1
• 231100000234 hepatic damage Toxicity 0.000 description 1
• 208000033552 hepatic porphyria Diseases 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 201000010284 hepatitis E Diseases 0.000 description 1
• 208000006359 hepatoblastoma Diseases 0.000 description 1
• 201000002735 hepatocellular adenoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 208000003215 hereditary nephritis Diseases 0.000 description 1
• 208000014188 hereditary optic neuropathy Diseases 0.000 description 1
• 208000008675 hereditary spastic paraplegia Diseases 0.000 description 1
• 208000009624 holoprosencephaly Diseases 0.000 description 1
• 208000008025 hordeolum Diseases 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 102000050172 human GRK1 Human genes 0.000 description 1
• 102000045091 human NRL Human genes 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 201000009075 hydranencephaly Diseases 0.000 description 1
• 208000003906 hydrocephalus Diseases 0.000 description 1
• GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
• 229940097277 hygromycin b Drugs 0.000 description 1
• 206010066130 hyper-IgM syndrome Diseases 0.000 description 1
• 208000013403 hyperactivity Diseases 0.000 description 1
• 201000001421 hyperglycemia Diseases 0.000 description 1
• 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
• 201000008980 hyperinsulinism Diseases 0.000 description 1
• 201000006318 hyperopia Diseases 0.000 description 1
• 230000004305 hyperopia Effects 0.000 description 1
• 201000010930 hyperostosis Diseases 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 208000022098 hypersensitivity pneumonitis Diseases 0.000 description 1
• 201000004108 hypersplenism Diseases 0.000 description 1
• 201000001948 hypertensive retinopathy Diseases 0.000 description 1
• 201000006866 hypopharynx cancer Diseases 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 206010021198 ichthyosis Diseases 0.000 description 1
• 208000009326 ileitis Diseases 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
• 208000023692 inborn mitochondrial myopathy Diseases 0.000 description 1
• 210000003000 inclusion body Anatomy 0.000 description 1
• 201000008319 inclusion body myositis Diseases 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 231100000405 induce cancer Toxicity 0.000 description 1
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 201000006747 infectious mononucleosis Diseases 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 230000004968 inflammatory condition Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 208000017532 inherited retinal dystrophy Diseases 0.000 description 1
• 230000000266 injurious effect Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 208000024710 intermittent asthma Diseases 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
• 201000009941 intracranial hypertension Diseases 0.000 description 1
• 208000001024 intrahepatic cholestasis Diseases 0.000 description 1
• 230000007872 intrahepatic cholestasis Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 208000037906 ischaemic injury Diseases 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 208000013049 isolated hemihyperplasia Diseases 0.000 description 1
• 210000001503 joint Anatomy 0.000 description 1
• 201000004815 juvenile spinal muscular atrophy Diseases 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 208000022013 kidney Wilms tumor Diseases 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 201000006370 kidney failure Diseases 0.000 description 1
• 210000003127 knee Anatomy 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
• 206010023683 lagophthalmos Diseases 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 208000004343 lateral medullary syndrome Diseases 0.000 description 1
• 208000008127 lead poisoning Diseases 0.000 description 1
• 201000003723 learning disability Diseases 0.000 description 1
• 210000002414 leg Anatomy 0.000 description 1
• 206010024217 lentigo Diseases 0.000 description 1
• 208000036546 leukodystrophy Diseases 0.000 description 1
• 210000003041 ligament Anatomy 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 208000014817 lissencephaly spectrum disease Diseases 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 230000008818 liver damage Effects 0.000 description 1
• 208000007903 liver failure Diseases 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 208000004731 long QT syndrome Diseases 0.000 description 1
• 201000002978 low tension glaucoma Diseases 0.000 description 1
• 230000004303 low vision Effects 0.000 description 1
• 201000005249 lung adenocarcinoma Diseases 0.000 description 1
• 201000009546 lung large cell carcinoma Diseases 0.000 description 1
• 201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
• 208000012804 lymphangiosarcoma Diseases 0.000 description 1
• 210000001365 lymphatic vessel Anatomy 0.000 description 1
• 208000005158 lymphoid interstitial pneumonia Diseases 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 201000007919 lymphoplasmacytic lymphoma Diseases 0.000 description 1
• 230000006216 lysine-methylation Effects 0.000 description 1
• 208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 201000010230 macular retinal edema Diseases 0.000 description 1
• 208000024714 major depressive disease Diseases 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 201000007924 marginal zone B-cell lymphoma Diseases 0.000 description 1
• 208000021937 marginal zone lymphoma Diseases 0.000 description 1
• 208000008585 mastocytosis Diseases 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 208000020968 mature T-cell and NK-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• HHRZAEJMHSGZNP-UHFFFAOYSA-N mebanazine Chemical compound NNC(C)C1=CC=CC=C1 HHRZAEJMHSGZNP-UHFFFAOYSA-N 0.000 description 1
• 208000030163 medullary breast carcinoma Diseases 0.000 description 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
• 201000008203 medulloepithelioma Diseases 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 201000008806 mesenchymal cell neoplasm Diseases 0.000 description 1
• 208000020140 mesenchymal hamartoma Diseases 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 208000010658 metastatic prostate carcinoma Diseases 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 108091078224 miR-344c stem-loop Proteins 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 208000004141 microcephaly Diseases 0.000 description 1
• 201000010478 microphthalmia Diseases 0.000 description 1
• 206010063344 microscopic polyangiitis Diseases 0.000 description 1
• 208000015994 miscarriage Diseases 0.000 description 1
• 201000011540 mitochondrial DNA depletion syndrome 4a Diseases 0.000 description 1
• 230000004065 mitochondrial dysfunction Effects 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 208000008588 molluscum contagiosum Diseases 0.000 description 1
• 201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 description 1
• 208000026114 mu chain disease Diseases 0.000 description 1
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
• 208000005340 mucopolysaccharidosis III Diseases 0.000 description 1
• 208000011045 mucopolysaccharidosis type 3 Diseases 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 206010065579 multifocal motor neuropathy Diseases 0.000 description 1
• 206010051747 multiple endocrine neoplasia Diseases 0.000 description 1
• 201000002077 muscle cancer Diseases 0.000 description 1
• 208000013465 muscle pain Diseases 0.000 description 1
• 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
• 230000036473 myasthenia Effects 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 201000005987 myeloid sarcoma Diseases 0.000 description 1
• 201000006387 myelophthisic anemia Diseases 0.000 description 1
• 208000001491 myopia Diseases 0.000 description 1
• 230000004379 myopia Effects 0.000 description 1
• 230000001016 myotrophic effect Effects 0.000 description 1
• 208000001611 myxosarcoma Diseases 0.000 description 1
• 201000003631 narcolepsy Diseases 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 210000000581 natural killer T-cell Anatomy 0.000 description 1
• 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
• 201000007970 necrotizing fasciitis Diseases 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 210000005170 neoplastic cell Anatomy 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 230000003767 neural control Effects 0.000 description 1
• 201000010193 neural tube defect Diseases 0.000 description 1
• 201000009494 neurilemmomatosis Diseases 0.000 description 1
• 210000002241 neurite Anatomy 0.000 description 1
• 201000002120 neuroendocrine carcinoma Diseases 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 208000018360 neuromuscular disease Diseases 0.000 description 1
• 210000000715 neuromuscular junction Anatomy 0.000 description 1
• 201000008051 neuronal ceroid lipofuscinosis Diseases 0.000 description 1
• 201000005734 nevoid basal cell carcinoma syndrome Diseases 0.000 description 1
• 230000003040 nociceptive effect Effects 0.000 description 1
• 244000309711 non-enveloped viruses Species 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 208000030459 obsessive-compulsive personality disease Diseases 0.000 description 1
• 208000014055 occupational lung disease Diseases 0.000 description 1
• 208000003177 ocular onchocerciasis Diseases 0.000 description 1
• 208000031237 olivopontocerebellar atrophy Diseases 0.000 description 1
• 206010030306 omphalitis Diseases 0.000 description 1
• 208000002042 onchocerciasis Diseases 0.000 description 1
• 208000005963 oophoritis Diseases 0.000 description 1
• 201000005040 opiate dependence Diseases 0.000 description 1
• 208000024196 oppositional defiant disease Diseases 0.000 description 1
• 201000002740 oral squamous cell carcinoma Diseases 0.000 description 1
• 201000005737 orchitis Diseases 0.000 description 1
• 208000014380 ornithine aminotransferase deficiency Diseases 0.000 description 1
• 201000006958 oropharynx cancer Diseases 0.000 description 1
• 208000005368 osteomalacia Diseases 0.000 description 1
• 208000002865 osteopetrosis Diseases 0.000 description 1
• 208000013371 ovarian adenocarcinoma Diseases 0.000 description 1
• 201000011029 ovarian embryonal carcinoma Diseases 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 108010090358 p300-CBP Transcription Factors Proteins 0.000 description 1
• 102000013034 p300-CBP Transcription Factors Human genes 0.000 description 1
• 208000005877 painful neuropathy Diseases 0.000 description 1
• 208000021090 palsy Diseases 0.000 description 1
• 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 1
• 208000019906 panic disease Diseases 0.000 description 1
• 208000002593 pantothenate kinase-associated neurodegeneration Diseases 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
• 208000012111 paraneoplastic syndrome Diseases 0.000 description 1
• 208000024817 paranoid personality disease Diseases 0.000 description 1
• 208000002851 paranoid schizophrenia Diseases 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 208000035824 paresthesia Diseases 0.000 description 1
• 230000001314 paroxysmal effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 201000001976 pemphigus vulgaris Diseases 0.000 description 1
• 208000008494 pericarditis Diseases 0.000 description 1
• 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
• 208000029308 periodic paralysis Diseases 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 201000003841 peripheral retinal degeneration Diseases 0.000 description 1
• 208000020930 peroxisome biogenesis disorder 1B Diseases 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• 229950010883 phencyclidine Drugs 0.000 description 1
• 210000004214 philadelphia chromosome Anatomy 0.000 description 1
• 208000001297 phlebitis Diseases 0.000 description 1
• CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 201000004123 pineal gland cancer Diseases 0.000 description 1
• 101150037186 pkc-1 gene Proteins 0.000 description 1
• 208000031223 plasma cell leukemia Diseases 0.000 description 1
• 208000010626 plasma cell neoplasm Diseases 0.000 description 1
• 208000008423 pleurisy Diseases 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 206010035653 pneumoconiosis Diseases 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 208000030761 polycystic kidney disease Diseases 0.000 description 1
• 208000028589 polycystic liver disease Diseases 0.000 description 1
• 208000003580 polydactyly Diseases 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 208000001061 polyostotic fibrous dysplasia Diseases 0.000 description 1
• 208000007232 portal hypertension Diseases 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 208000028173 post-traumatic stress disease Diseases 0.000 description 1
• 208000037955 postinfectious encephalomyelitis Diseases 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 201000007271 pre-malignant neoplasm Diseases 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 201000011174 precursor lymphoblastic lymphoma/leukemia Diseases 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 201000010041 presbyopia Diseases 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 208000018290 primary dysautonomia Diseases 0.000 description 1
• 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
• 201000006037 primary mediastinal B-cell lymphoma Diseases 0.000 description 1
• 201000000742 primary sclerosing cholangitis Diseases 0.000 description 1
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
• 201000002212 progressive supranuclear palsy Diseases 0.000 description 1
• 201000005825 prostate adenocarcinoma Diseases 0.000 description 1
• 201000007094 prostatitis Diseases 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 201000003004 ptosis Diseases 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
• 210000001747 pupil Anatomy 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 229910052705 radium Inorganic materials 0.000 description 1
• HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
• 101150024910 rbp4 gene Proteins 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 108010054624 red fluorescent protein Proteins 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 208000014733 refractive error Diseases 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000000754 repressing effect Effects 0.000 description 1
• 230000001718 repressive effect Effects 0.000 description 1
• 201000006845 reticulosarcoma Diseases 0.000 description 1
• 208000029922 reticulum cell sarcoma Diseases 0.000 description 1
• 230000004243 retinal function Effects 0.000 description 1
• 150000004492 retinoid derivatives Chemical class 0.000 description 1
• 102000027483 retinoid hormone receptors Human genes 0.000 description 1
• 108091008679 retinoid hormone receptors Proteins 0.000 description 1
• 201000007714 retinoschisis Diseases 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 208000004124 rheumatic heart disease Diseases 0.000 description 1
• 208000021569 rheumatoid lung disease Diseases 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 208000007442 rickets Diseases 0.000 description 1
• 102220278926 rs759871071 Human genes 0.000 description 1
• 238000007665 sagging Methods 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• 230000037390 scarring Effects 0.000 description 1
• 208000022610 schizoaffective disease Diseases 0.000 description 1
• 210000003786 sclera Anatomy 0.000 description 1
• 206010039722 scoliosis Diseases 0.000 description 1
• 210000004706 scrotum Anatomy 0.000 description 1
• 208000014956 scrotum Paget disease Diseases 0.000 description 1
• 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
• 201000003385 seborrheic keratosis Diseases 0.000 description 1
• 239000000932 sedative agent Substances 0.000 description 1
• 230000001624 sedative effect Effects 0.000 description 1
• 201000005574 senile angioma Diseases 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 208000025874 separation anxiety disease Diseases 0.000 description 1
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 208000031162 sideroblastic anemia Diseases 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 201000000195 skin tag Diseases 0.000 description 1
• 201000002859 sleep apnea Diseases 0.000 description 1
• 208000019116 sleep disease Diseases 0.000 description 1
• 101150018914 smagp gene Proteins 0.000 description 1
• 201000000824 solar retinopathy Diseases 0.000 description 1
• 102000004052 somatostatin receptor 2 Human genes 0.000 description 1
• 208000018198 spasticity Diseases 0.000 description 1
• 201000001716 specific phobia Diseases 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 208000020431 spinal cord injury Diseases 0.000 description 1
• 206010062261 spinal cord neoplasm Diseases 0.000 description 1
• 208000037959 spinal tumor Diseases 0.000 description 1
• 201000002471 spleen cancer Diseases 0.000 description 1
• 208000027140 splenic disease Diseases 0.000 description 1
• 206010062113 splenic marginal zone lymphoma Diseases 0.000 description 1
• 208000005801 spondylosis Diseases 0.000 description 1
• 208000000995 spontaneous abortion Diseases 0.000 description 1
• 208000017572 squamous cell neoplasm Diseases 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 208000003265 stomatitis Diseases 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 230000036561 sun exposure Effects 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 201000010965 sweat gland carcinoma Diseases 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• 206010042863 synovial sarcoma Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 101150003389 tdh2 gene Proteins 0.000 description 1
• 101150088047 tdh3 gene Proteins 0.000 description 1
• 201000004415 tendinitis Diseases 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 101150061166 tetR gene Proteins 0.000 description 1
• 201000006361 tethered spinal cord syndrome Diseases 0.000 description 1
• OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 206010043554 thrombocytopenia Diseases 0.000 description 1
• 208000018657 thygeson superficial punctate keratopathy Diseases 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 102000004217 thyroid hormone receptors Human genes 0.000 description 1
• 108090000721 thyroid hormone receptors Proteins 0.000 description 1
• 206010044008 tonsillitis Diseases 0.000 description 1
• 208000004371 toothache Diseases 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 208000002419 toxicodendron dermatitis Diseases 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 101150117196 tra-1 gene Proteins 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 201000010875 transient cerebral ischemia Diseases 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 201000006532 trichorhinophalangeal syndrome type II Diseases 0.000 description 1
• 206010044652 trigeminal neuralgia Diseases 0.000 description 1
• 201000002311 trypanosomiasis Diseases 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 208000009999 tuberous sclerosis Diseases 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 230000005740 tumor formation Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 208000032471 type 1 spinal muscular atrophy Diseases 0.000 description 1
• 208000032527 type III spinal muscular atrophy Diseases 0.000 description 1
• 230000005951 type IV hypersensitivity Effects 0.000 description 1
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
• 201000008297 typhoid fever Diseases 0.000 description 1
• 208000022810 undifferentiated (embryonal) sarcoma Diseases 0.000 description 1
• 208000000143 urethritis Diseases 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 208000037965 uterine sarcoma Diseases 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• 208000027185 varicose disease Diseases 0.000 description 1
• 201000011531 vascular cancer Diseases 0.000 description 1
• 201000000866 velocardiofacial syndrome Diseases 0.000 description 1
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
• 229960004528 vincristine Drugs 0.000 description 1
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
• 201000001862 viral hepatitis Diseases 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 208000009935 visceral pain Diseases 0.000 description 1
• 230000004393 visual impairment Effects 0.000 description 1
• 230000004400 visual pathway Effects 0.000 description 1
• 210000000239 visual pathway Anatomy 0.000 description 1
• 230000006516 vital cellular process Effects 0.000 description 1
• 201000007790 vitelliform macular dystrophy Diseases 0.000 description 1
• 210000004127 vitreous body Anatomy 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 208000028010 vulval Paget disease Diseases 0.000 description 1
• 208000002003 vulvitis Diseases 0.000 description 1
• 208000010484 vulvovaginitis Diseases 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 230000037303 wrinkles Effects 0.000 description 1
• 208000005494 xerophthalmia Diseases 0.000 description 1
• 101150032601 yejM gene Proteins 0.000 description 1